8/09 CURRICULUM VITAE · Urologic Clinics: Advances in Incontinence Surgery. ed R Dmochowski. WB...

1

8/09 CURRICULUM VITAE

Roger Roman Dmochowski, M.D. EDUCATION: 7/1972-6/1976 St. Thomas H.S. Houston, Texas (Honors) 7/1976-6/1979 Trinity University San Antonio, Texas Bachelor of Arts (6/79) (Summa Cum Laude) 7/1979-6/1983 The University of Texas Medical Branch Galveston, Texas M.D. (6/83) (Summa Cum Laude) HONORS AWARDS AND OTHER RECOGNITION: 1976-1979 National Merit Scholarship 1976-1979 Trustee Scholarship Trinity University 1976-1979 Welch Foundation Scholar 1977-1979 President's Scholarship

Trinity University 1979 Phi Beta Kappa 1980 Anne Lassiter Award

University of Texas Medical Branch 1981 Golden Cane Award

University of Texas Medical Branch 1982 Alpha Omega Alpha 1983 Alpha Omega Alpha Scholarship Award 1999 Zimskind Award (Urodynamics Society) 2004 Pfizer Visiting Professor Scholarship (Tulane University) 2005 - 2007 America’s Best Doctor’s 2006 Honorary Member Thai Urologic Association 2005 - 2008 Who’s Who In American Medicine 2007 HMDP Visiting Expert, Singapore 2007 American Association of Genitourinary Surgeons 2007 J Urology, Best reviewer, Urodynamics/Female Urology/Incontinence 2008 European Urology, Reviewer of the Month 2008 Presidential Citation, American Urologic Association 2009 NAFC, Rodney Appell Continence Care Champion 2009 Frank Boehme Teaching Award, Vanderbilt University Medical Center

2

POSTGRADUATE TRAINING: Internship: 7/1983 - 6/1984 University of Texas Medical School at Houston Houston, Texas Surgery Residency 7/1984-6/1985 University of Texas Medical School at Houston Houston, Texas Surgery 7/1985-6/1989 University of Texas Medical School at Houston and M.D. Anderson Hospital and Tumor Institute Houston, Texas Urology Subspecialty Training 1986 Genitourinary Laser Surgery M.D. Anderson Hospital and Tumor Institute Houston, Texas

1987 Microvascular Surgery Jesse H. Jones and Mary Gibbs Jones Microsurgical Training Laboratory St. Joseph Hospital Houston, Texas

1987 Extra-Corporeal Shock Wave Lithotripsy St. Joseph Hospital and The University of Texas Medical School at Houston, Texas

1992 Laparoscopy Naval Hospital, Portsmouth, Virginia

FELLOWSHIP: Female Urology, Urodynamics, Prosthetics Department of Urology, Kaiser Permanente Los Angeles, California BOARD CERTIFICATION: American Board Of Urology February 1991; Recertification 2 /1999 (exp. 2/2011), Recertification 3 /2008 (exp.

2/2021) LICENSURE: State of Texas State of California State of Tennessee PROFESSIONAL ORGANIZATIONS:

3

1983-1994 Harris County (Texas) Medical Society 1983 -1994 Texas Medical Association 1992 -Present Member, American Urologic Association (AUA) 1995 - Present Southeastern Section, AUA 1992 -Present Fellow, American College of Surgeons 1989 -Present Society of Government Service Urologists 1994 -Present Urodynamic Society, Full Member 1995 -Present Society of Genitourinary Reconstructive Surgeons 1995 -Present Societe’ Internationale d’Urologie 1995 -Present American Urogynecologic Society 1995 -Present Society of University Urologists 1996 -Present International Continence Society ACADEMIC APPOINTMENTS: 1989-1993 Staff Urologist, Naval Hospital Portsmouth, Va. 1990-1993 Director of Resident Education (Research) Clinical Assistant Professor (Urology) Eastern Virginia Medical School Norfolk, Virginia 1990-1991 Clinical Instructor in Surgery Uniformed Services University of the Health Sciences, Bethesda, Maryland 1991-Present Clinical Assistant Professor in Surgery Uniformed Services University of the Health Sciences, Bethesda, Maryland 1994 - 1995 Assistant Professor Dept. of Urology University of Tennessee, Memphis, Tennessee 1996 - 1998 Associate Professor

4

Departments of Urology/Gynecology Director , Division of Neurourology University of Tennessee, Memphis, Tennessee 1998 – 2001 Medical Director, North Texas Center for Urinary Control 2002 – Present Professor Dept. of Urology Director of Female Pelvic Medicine and Reconstructive Urology Fellowship Vanderbilt University Nashville, Tn. HOSPITAL APPOINTMENTS: 1989-1993 Staff Urologist Naval Hospital Portsmouth, Virginia 1992-1993 Consultant in Urology Langley Air Force Base, Hampton, Virginia 1995 - 1998 U.T. Bowld Hospital Active Staff 1995 - 1998 Baptist Memorial Hospital, Memphis, Tennessee Active Staff 1995 - 1998 Veteran's Administration Hospital Memphis, Tennessee Active Staff 1995 - 1998 Regional Medical Center, Memphis, Tennessee Active Staff 1995 - 1998 LeBonheur Children's Hospital Consulting Staff 1995 - 1998 Methodist Hospital, Memphis. Tennessee Consulting Staff 1997 - 1998 St. Francis Hospital, Memphis, Tennessee Consulting Staff 1998 – 2001 Harris Methodist Hospital, Fort Worth, Texas Active Staff All Saints Hospital, Fort Worth, Texas Active Staff Columbia Plaza Medical Center, Fort Worth, Texas Active Staff Campbell Hospital, Weatherford, Texas Consulting Staff Palo Pinto Hospital, Mineral Wells, Texas Consulting Staff Arlington Memorial Hospital, Arlington, Texas Consulting Staff Columbia South Arlington, Arlington, Texas Consulting Staff PAST HOSPITAL/CLINIC AFFILIATIONS: Center For Urinary Control - Medical Director U.T. Bowld Hospital Urodynamics Lab - Medical Director

5

V.A.M.C. Memphis, Spinal Cord Unit - Director of Urology EDITORIAL APPOINTMENTS: Journal Affiliations Editorial Board: British Journal of Urology International Editorial Board: World Journal of Urology Editorial Board: European Journal of Urology Editorial Board: Journal of Pelvic Medicine Editorial Board: AUA Office of Education, CD Rom Series Editorial Board: Neurourology and Urodynamics (Section Editor: Male voiding dysfunction) 2004 – 2007 (Associate Editor) 2009 - Present Editorial Board: American Journal of Urology Editorial Board: International Journal of Urogynecology ((Section Editor: Pharmacology)) Editorial Board: International Brazilian Journal of Urology (Consulting Editor: Female

Urology/Neurourlogy) Editorial Board: LUTS Reviewer: Journal of Urology Urology British Medical Journal International Journal of Urogynecology British Journal of Urology International BOOK CHAPTERS:

1. Dmochowski Roger, Myazaki F., Zimmern P., Leach Gary: Vaginal Anatomy and Preoperative Preparation for Vaginal Surgery. Atlas of the Urologic Clinics of North America, 2:1,p.1-12, April, 1994.

2. Dmochowski Roger, Zimmern P.E., Leach G. E.: Female Urology and Incontinence. Practical cases in Urology. Series XVII, Number 1,1994.

3. Dmochowski R., Leach G.E.: Bladder Dysfunction and Urinary Incontinence in Primary Care and General Medicine, J. Noble (ed.), Mosby Publications, 1994.

4 K. Ganabathi K., Dmochowski R., Leach G., Zimmern G.E.: Investigation of Male Urinary Incontinence. Part I. Evaluation and Imaging. Monographs on Diagnosis and Treatment of Pelvic Floor Dysfunction. Hollister, 1994.

5. K. Ganabathi K., Dmochowski R., Leach G., Zimmern P.E.: Investigation of Male Urinary Incontinence. Part II: Urodynamics. Monographs on Diagnosis and Treatment of Pelvic Floor Dysfunction. Hollister, Inc. 1994.

6. K. Ganabathi K., Dmochowski R., Leach G., Zimmern P.E.: Treatment of Urinary Incontinence in Men. Part I: Urge Incontinence. Monographs on Diagnosis and Treatment of Pelvic Floor Dysfunction. Hollister, Inc. 1994.

7. K. Ganabathi K., Dmochowski R., Leach G., Zimmern P.E.: Treatment of Urinary Incontinence in Men. Part II: Stress Incontinence. Monographs on Diagnosis and Treatment of Pelvic Floor Dysfunction. Hollister, Inc. 1994.

8. Dmochowski, R.: Commentary: Suprapubic Cystostomy, Atlas of Urologic Surgery, Second Edition, W.B. Saunders, 1995.

9. Leach G., Dmochowski R., Appell R., Blaivas J.G., Hadley R., Luber K., Mostwin J.,O'Donnell P.: Female Stress Urinary Incontinence Clinical Guidelines Panel Summary Report on Surgical Treatment of Female Stress Urinary Incontinence.American Urologic Association. June 1997.

10. Dmochowski RR: Normal and Abnormal Cystoscopic Diagnoses. Evaluation of the Female Urinary Tract. B. Miller (ed). W.B. Saunders. 1997.

6

11. Dmochowski RR: Outcomes and Incontinence; Current status of results reporting. In Textbook of Female Urology and Urogynecology. D. Staskin and L. Cardozo (ed.) Isis Medical, 1999.

12. Dmochowski RR: Urinary Retention in Women. In Voiding Dysfunction. R.A. Appell (ed) Humana Press, 1999. 13. Dmochowski RR: Urinary Incontinence. In, Conn’s Current Therapy 2000. R Rakel (ed), W.B.Saunders, Philadelphia, 1999. 14. Dmochowski RR: Surgery for Vesicovaginal fistulas, urethrovaginal fistulas and urethral diverticula. Campbell’s Urology, 2000. 15. Smith A, Dmochowski R, Danishgari F, Jarvis J, Nitti V, Valparaiso M. Surgical treatment

for genuine stress urinary incontinence. Ed. Abrams P, Wein A, Khouri S, Cardozo L. World Health Organization 2nd International Consultation on Incontinence, Paris, 2001.

16. Dmochowski RR, Gomelsky A. Cystocele repair and anterior vaginal prolapse. Glenn’s Operative Urology. 2002 17. Gomelsky A, Dmochowski RR. Female Urology .Practical Cases in Urology. Series XXV,

Number 1, 2003. 18. The Public Health Implication of Urogenital Disease: A Focus on the Overactive Bladder, US

Dept of Health and Human Services – Office of Women’s Health, 2003. 19. Scarpero H, Dmochowski R. Pelvic Anatomy for the Surgeon. In Multidisciplinary

Management of Female Pelvic Floor Dysfunction. ed C Chapple, P Zimmern, L Brubaker, ARB Smith, C Norton, K Bo. Elsevier Science, London

20. Dmochowski R, Scarpero H. Vesicovaginal and Urethrovaginal Fistulae. In Multidisciplinary Management of Female Pelvic Floor Dysfunction. ed C Chapple, P Zimmern, L Brubaker, ARB Smith, C Norton, K Bo. Elsevier Science, London

21. Scarpero HM, Dmochowski RR, Leu PB. Female Urethral Diverticula. In Atlas of the Urologic Clinics: Advances in Incontinence Surgery. ed R Dmochowski. WB Saunders Inc, Philadelphia.

22. Leu PB, Scarpero HM, Dmochowski RR. Cystocele repair with interpositional grafting. In Atlas of the Urologic Clinics: Advances in Incontinence Surgery. ed R Dmochowski. WB Saunders Inc, Philadelphia.

23. Herrell SD, Dmochowski R. Robotic pelvic prolapse surgery. In Atlas of the Urologic Clinics: Advances in Incontinence Surgery. ed R Dmochowski. WB Saunders Inc, Philadelphia.

24. Gomelsky A, Dmochowski R. Pubovaginal Slings. In Vaginal Surgery. Ed C Zimmerman and L Kovac. W B Saunders Inc, Philadephia.

24. Cole E, Scarpero H, Dmochowski R. The Assessment of Outcomes Used for Incontinence Interventions in Women. Textbook of Female Urology and Urogynecology. D. Staskin and L. Cardozo (ed.) Isis Medical, 2005.

25. Cole E, Scarpero H, Dmochowski R. The Artificial Urinary Sphincter for Treatment of Stress Urinary Incontinence in Women. Textbook of Female Urology and Urogynecology. D. Staskin and L. Cardozo (ed.) Isis Medical, 2005.

26. Scarpero H, Cole E, Dmochowski R. Biological Materials for Reconstructive Surgery.

Textbook of Female Urology and Urogynecology. D. Staskin and L. Cardozo (ed.) Isis Medical, 2005.

27. Scarpero H, Cole E, Dmochowski R. An Overview of Pubovaginal Slings: Evolution of Technology. Textbook of Female Urology and Urogynecology. D. Staskin and L. Cardozo (ed.) Isis Medical, 2005.

28. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Milbank A, Nehra A, Sharlip ID. The management of erectile dysfunction: an AUA update. American

7

Urologic Association, 2005. 29. Smith A, Dmochowski R, Danishgari F, Miller K, Valparaiso M. Surgical treatment

for genuine stress urinary incontinence. Ed. Abrams P, Wein A, Khouri S, Cardozo L. World Health Organization 3rd International Consultation on Incontinence, Monaco, 2004.

30. Starkman J, Scarpero H, Dmochowski R. Transobturator Tape Procedures Technology. Textbook of Female Urology and Urogynecology. D. Staskin and L. Cardozo (ed.) Isis Medical, 2005.

31. Cole E, Dmochowski R. Radiofrequency treatment for the management of genuine stress urinary incontinence. Textbook of Female Urology. L Rodgriguez and S Raz (ed). W B Saunders 2006.

32. Dmochowski R, Scarpero H, Starkman J. Mid-urethral slings. Wein, Kavoussi, Partin (ed).in Campbell’s Urology. WB Saunders, 2006.

33. Dmochowski R. Overactive Bladder: Management Guide. Thompson; PDR, 2005 34. Dmochowski R, Scarpero H. Mixed Incontinence. Goldman and Vasavada (ed), Humana

Press, 2006 35. Starkman JS, Kreder K, Dmochowski R. Tolterodine. Kreder K, Dmochowski R (ed). The

Overactive Bladder. Springer, London, 2007. 36. Dmochowski R, Kreder K. Fesoterodine. Kreder K, Dmochowski R (ed). The Overactive

Bladder. Springer, London, 2007. 37. Wein AJ, Dmochowski R. Outcomes for incontinence trials. Kreder K, Dmochowski R (ed).

The Overactive Bladder. Springer, London, 2007. 38. Dmochowski R. Kreder K. Solefenacin. Kreder K, Dmochowski R (ed). The Overactive

Bladder. Springer, London, 2007. 39. Starkman J, Scarpero H, Dmochowski R. Cerebrovascular accidents, intracranial tumors and

urologic consequences. Schick E, Corcos J(ed). The Neurogenic Bladder. 40. Kaufman M, Scarpero HM, Dmochowski RR. Cystocele repair and anterior vaginal prolapse.

Glenn’s Operative Urology. 2008. 41. Wolter C, Scarpero HS, Dmochowski R. Cerebrovascular accidents, intracranial tumors, and

urologic consequences.Textbook of the Neurogenic Bladder. 2nd ed. Corcos and Shcick (ed). Informa Healthcare, London 2008.

42. Kaufman, M.R., Scarpero, H.S., and R.R. Dmochowski (2009) Complications of SUI surgery. In: Textbook of Female Urology and Urogynecology. L. Cardoza and D. Staskin, eds.

43. Gomelsky A, Dmochowski R. Transobturator slings(2009).. In: Textbook of Female Urology and Urogynecology. L. Cardoza and D. Staskin, eds

44 Dmochowski R, Staskin D. The Artificial sphincter for female stress urinary incontinence. (2009). In: Textbook of Female Urology and Urogynecology. L. Cardoza and D. Staskin, eds. (2009)

45. Reynolds William S, Dmochowski R. Injectable therapy. (2009). In: Textbook of Female Urology and Urogynecology. L. Cardoza and D. Staskin, eds.

46. Kaufman, M.R.and R.R. Dmochowski (2009) Venous thromboembolism: Risks and prophylaxis in urologic surgery (2009). In P. Dahm, R Dmochowski ed. Evidence-based Urology.

47. Gomelsky A, Dmochowski R. Surgical Treatment of female urinary incontinence. In P. Dahm, R Dmochowski ed. Evidence-based Urology.

Books Kreder K, Dmochowski R (ed). The Overactive Bladder. Springer, London, 2007. Hashim H, Abrams P, Dmochowski R. (ed) Urologic Procedures. Springer, London 2006.

8

Cardozo L, Staskin D. (ed) Female Urology and Urogynecology. Springer, London, 2005 R Dmochowski Section editor PUBLICATIONS: 1. Clyde D., Bertini J., Dmochowski R., Koop H.: The Vitamin A and C Content of

Coriandrum Sativum and the Variations in the Loss of the Latter with Various Methods of Food Preparation and Preservation. Qualitas Plantarum, Vol.28,1979.

2. Dmochowski R., and Corriere J.N., Jr.: Bladder Injury and Uroascites From Umbilical

Arterial Catheterization. Pediatrics 77 :421-422,1986.

3. Wishnow K., and Dmochowski R.: Pelvic Recurrence After Radical Cystectomy Without Pre-Operative Irradiation. J. Urol. 140:42-44, 1988.

4. Wishnow K., Johnson D., Dmochowski R., and Chong C.: The Ileal Conduit in the Era of

Systemic Chemotherapy. Urology 33(5)358-361,1989.

5. Dmochowski R., Rudy D.C., Weitzner S., and Corriere, J.N., Jr.: Simple Cyst of the Testis. J. Urol. 142:1078-1080,1989.

6. Dmochowski R., Rudy D.C.: Bladder Contracture Following Intravesical Doxorubicin

Therapy: Case Report and Review of Literature. J. Urol. 143:816-818, 1990.

7. Han P., Dmochowski R., Blasser M., Auman J.R.: Segmental Infarction of the Testis. J. Urol. 151:115,1994.

8. Leach G E., Sirs L, Ganabathi K., Roskamp D., Dmochowski R: Visual Laser Prostatectomy

with Local Anesthesia. Urol. 43:149,1994. 9. Ganabathi K., Leach G.E., Zimmern P.E., Dmochowski R.: Experience with the

Management of Urethral Diverticulum in 63 Women. J. Urol., 152:1445-1448, 1994.

10. Dmochowski R., Ganabathi K., Leach G., Zimmern P.E.: Benign Female Periurethral Masses. J. Urol., 152: 1943-1951,1994.

11. Bildsten S.,Dmochowski R., Auman J.R., Spindel M.: The Risk of Rhabdomyolysis and

Renal Failure with Prolonged Extended Lithotomy Position. J. Urol., 152: 1970-1972,1994. 12. Ganabathi K., Dmochowski R., Zimmern P.E., Leach G.E.: Prevention and Management of

Urovaginal Fistulas. Urologic Panamericana. 6(2): 91-106,1994.

13. Dmochowski R., Ganabathi K., and Leach G.E.: Non-operative Management of Spinal Cord Injury. Neurourol. Urodyn., 14(1):47-55, 1995.

14. Ganabathi K., Dmochowski R., Leach G.E., and Zimmern P.E.: Peyronie's Disease: Surgical Treatment Based on Penile Rigidity. J. Urol., 153:662-665, 1995.

9

15. Docimo S.G., Dmochowski R., Remmenga S., Segne R.: Hysterectomy via the Transvaginal Approach after Intestinal Bladder Augmentation and Psoas Hitch Reimplant: Case Report and Review of the Literature. J. Am . CoIl. Surg. 180:610-612,1995.

16. K. Ganabathi, Dmochcwski R., Zimmern P.E., Leach G.E.: Diverticula of the Female

Urethra. Progress en Urologie. 5: 335 - 351,1995. 17. Dmochowski P., Littlejohn J., Cox G.E., Amiri H., Hathaway D.K., Gaber 0.: Stability of

Bladder Function Two Years Following Simultaneous Pancreas-Kidney Transplantation. Trans. Proc. 27 (6): 3127,1995.

18. Goldman H., Dmochowski P., Cox G.E.: Twenty Six Cases of Penetrating Trauma to the

Penis: Functional Results. J. Urol. 155:551-553, 1996. 19. Goldman H., Dmochowski R., Nee H.N.: Nephrogenic Adenoma Occurring in an Augmented Bladder. J. Urol. 155:1410,1996. 20. Stonehill W., Dmochowski R., Patterson A. L., Cox C.E.: Risk Factors For Bladder Tumors

In Spinal Cord Injury Patients. J. Urol. 155:1248 - 1250,1996. 21. Appell R.A., Rackley R.R., Dmochowski R.: Vesica Percutaneous Bladder Neck

Stabilization. J of Endourol. 10 (3): 221 - 226, 1996. 22. Dmochowski R.: Cystometry. Urol Clin North Am. 23(2): 243 - 252,1996. 23. Trockman B.A., Gerspach J., Dmochowski R., Haab F., Zimmern P.E., Leach G.E.:

Primary Bladder Neck Obstruction: Urodynamic Findings and Treatment Results in 36 Men. J Urol 156:1418 - 1420,1996.

24. Samm B., Dmochowski R.: Urologic Emergencies: Early Recognition and Management.

(Part I) Postgrad. Med. 100:177-186, 1996. 25. Samm B., Dmochowski R.: Urologic Emergencies: Early Recognition and Management.

(Part II) Postgrad. Med. 100:187-200,1996. 26. Dmochowski R., Appell R.A.: Percutaneous Bladder Neck Suspension. Techniques in

Urology. 1996. 27. Goldman H, Dmochowski R.: Erosion of Venal Caval Filter as Cause of Urinary

Extravasation. J Urol 156:1763,1996. 28. Dmochowski R., Ganabathi K., Sirls L., Zimmern P.E., Leach G.E.: The Four Corner

Bladder Neck Suspension: A Subjective and Objective Evaluation. Urol. 49: 35-40,1997.

29. Hollabaugh RS, Dmochowski R., Steiner M.S.: The Neuroanatomy of The Male Rhabdosphincter. Urol. 49:426 - 434,1997.

30. Goldman H., Dmochowski R.: Lower Urinary Tract Dysfunction in Patients with

Gastroparesis. J. Urol. 157:1823-1826, 1997.

10

31 Stonehill W.R., Goldman H.B., Dmochowski R.: The Utility of Urinary Cytology for

Diagnosing Bladder Tumors in Spinal Cord Injury Patients. J.Urol.157: 2210, 1997. 32. Leach G., Dmochowski R., Appell R., Blaivas J.G., Hadley R., Luber K., Mostwin J.,

O'Donnell P.: Female Stress Urinary Incontinence Clinical Guidelines Panel. Summary Report on Surgical Treatment of Female Stress Urinary Incontinence. J. Urol. 158: 850, 1997. 33. Haab F, Dmochowski RR, Zimmern PE, Leach GE.: A Study on the Effect of Bladder

Volume on Valsalva Leak Point Pressure Determination. Progres En Urologie. 7: 422- 425, 1997.

34. Hollabaugh RS, Dmochowski RR, Hickerson RI, Cox CE: Fournier's Gangrene:

Therapeutic Impact of Hyperbaric Oxygen. J. Plast. Recont Surg. 101:94, 1998. 35. Gubin DA, Dmochowski RR, Kutteh WA: Mulitvariant Analysis of Men from Infertile

Couples With and Without Antisperm Antibodies. American Journal of Reproductive Immunology. 39:157 – 160, 1998.

36. Goldman HB, Idom CB, Dmochowski RR: Penetrating Trauma of the Female External

Genitalia and the Association with Urologic Injury. J Urol 159: 956-959, 1998. 37. Hollabaugh RS, Dmochowski RR, Kneib TG, Steiner MS: Preservation of Putative

Continence Nerves During Radical Retropubic Prostatectomy Leads to More Rapid Return of Urinary Continence. Urol. 51: 970, 1998.

38. Shirwany A, Sargent SS, Dmochowski RR, Bronze MS. Urinary tract aspergillosis in a renal

transplant recipient. Clin Inf Dis. 27; 1339, 1998. 39. Dmochowski RR: Female Voiding Dysfunction and Movement Disorders. Int J Urogyn.10:

144-151, 1999. 40. Goldman H, Stonehill W, Dmochowski R: Bladder Histological Changes Associated with

Chronic Indwelling Urinary Catheters. J Urol. 161, 1999. 41. Kobashi KC, Dmochowski R, Mee SL, Mostwin J, Nitti V, Zimmern PE, Leach GE: Erosion

of woven polyester synthetic (Protogen) pubovaginal sling. J Urol. 162, 2070-2072, 1999. 42. Weld K, Dmochowski RR: Effect of bladder management on urological complications in

spinal cord injury patients. J Urol 163:768-772, 2000. 43. Weld K, Graney MJ, Dmochowski RR: Differences in bladder compliance over time and

associations of bladder management with compliance in spinal cord injury patients. J Urol 163:1228-1233, 2000.

44. Weld K, Dmochowski RR: Association of level of injury and bladder behavior in post

traumatic spinal cord injury patients. Urol 55; 420 – 424, 2000.

11

45. Weld K, Dmochowski RR: Clinical significance of detrusor sphincter dyssynergia type in patients with traumatic spinal cord injury. Urol 56; 565 – 568, 2000.

46. Weld K, Wall BM, Mangold TA, Stere EL, Dmochowski RR: Influences on Renal function in

Chronic Spinal Cord Injured Patients. J Urol 164(5): 1490 – 1493, 2000. 47. Hollabaugh RS, Steiner MS, Sellers KD, Samm BJ, Dmochowski RR: Neuroanatomy of the

Pelvis: Implications for Colonic and Rectal Resection. Dis Col Rect. 43(10); 1390 –1397, 2000.

48. Dmochowski RR, Appell R. Injectable agents in the treatment of female stress urinary

incontinence: where are we now? Urol 56 (4); 32 –40, 2000. 49. Dmochowski RR, Appell R. Advancements in the pharmacologic management of the

overactive bladder. Urol 56 (4); 41 –49, 2000. 50. Appell RAA, Sand P, Dmochowski RR, Anderson R, Zinner N, Lama D, Roach M, Miklos J,

Saltzstein, Boone T, Staskin D, Albrecht D. Comparison of the Efficacy and Tolerability of Extended Release Oxybutynin Chloride, and Tolterodine Tartrate in the Treatment of Overactive Bladder – Results of the Object Study. Mayo Clin Proc 76 (4): 358 – 363, 2001.

51. Wall BM, Dmochowski RR, Malecha M, Mangold T, Bobal M: Inducible Nitric Oxide

Synthase in urinary bladders from spinal cord injury patients with chronic indwelling urinary catheters.. J Urol 165:1457 –1461, 2001.

52. Hollabaugh RS, Steiner MS, , Dmochowski RR: Neuroanatomy of the female continence

complex: clinical implications. Urol. 57(2); 382-388, 2001. 53. Dmochowski RR, Appell R. Delivery of injectable agents in the treatment of female stress

urinary incontinence: evolving strategies. Tech In Urol. 7; 110-117, 2001. 54. Weber AW, Abrams P, Brubaker L, Cundiff G, Davis WM, Dmochowski R, Fischer J, Hull

T, Nygaard I, Weidner A: Standardization of Terminology for Researchers in Female Pelvic Floor Disorders. Int Urogyn J 12; 178 – 186, 2001.

55. Dmochowski RR. Urethral diverticula: Evolving diagnostics and improved surgical

management. Curr Urol. Rep. 2001. 56. Dmochowski RR, Kell S, Staskin DR. Oxybutynin Chloride: Alterations in Drug Delivery

and Improved Therapeutic Index. Expert Opin Pharmacother 3(4); 443- 454, 2002. 57. Nitti VW, Carlson KV, Blaivas JG, Dmochowski RR. A simplified method of pubovaginal

sling lysis: description and early results. Urology 59(1); 47 -51, 2002. 58. Wilson TW, Lemack G, Dmochowski RR. Urolume Stents: Lessons Learned. J Urol 167;

2477-2480, 2002.

12

59. Barnes NM, Dmochowski RR, Park R, Nitti VW. Pubovaginal sling and pelvic prolapse repair in women with occult stress urinary incontinence: effect on postoperative emptying and voiding symptoms. Urology 59(6); 856 – 860, 2002.

60. Dmochowski RR, Davila GW, Zinner NR, Gittelman MC, Saltzstein DR, Lyttle S, Sanders S.

Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence. J Urol 168; 580 -586, 2002.

61. Cespedes RD, Dmochowski RR. The diagnosis and treatment of vaginal prolapse conditions.

Part 1: Pelvic Anatomy, cystocele, rectocele. AUA Update Series. Vol 31, 2002. 62. Cespedes RD, Dmochowski RR. The diagnosis and treatment of vaginal prolapse conditions.

Part 2: Enterocele, uterine and vault prolapse. AUA Update Series.Vol. 31, 2002. 63. Graham CG, Dmochowski RR: Questionnaires for women with lower urinary tract symptoms.

Neurourology Urodyn 21(5); 473- 581, 2002. 64. Dmochowski RR. Management of postoperative overactive bladder complications. Geriatrics

57; (S) 18 -23, 2002. 65. Dmochowski RR . Radio Frequency Bladder Neck Suspension for the Treatment of Genuine

Stress Urinary Incontinence. Curr Urol Rep 3(5); 378 -381, 2002. 66. Scarpero HM, Dmochowski RR, Nitti VW: Repeat urethrolysis following failed urethrolysis

for iatrogenic obstruction. J Urol 169; 1013 - 1016, 2003. 67. Graham C, Dmochowski RR. Pubic Osteomyelitis following bladder neck surgery using bone

anchors: report of nine cases. J Urol 168; 2055 -2058, 2002. 68. Kershen RT, Dmochowski RR, Appell RA. Injectable therapies for the treatment of female

stress urinary incontinence in the new millennium. Urol Clin NA 29; 559 – 574, 2002. 69. Dmochowski RR, Staskin D. The overactive bladder in men; Special considerations for

evaluation and management. Urol 60 (5A), 56 – 63, 2002. 70. Staskin DR, Dmochowski RR. Future studies for overactive bladder: the need for

standardization. Urol 60 (5A), 90 - 94, 2002. 71. DmochowskiRR, Staskin DR. Advances in drug delivery: Improved bioavailability and drug

effect. Curr Urol Rep 3: 439 – 444, 2002. 72. Dmochowski RR, Avon M, Ross J, Cooper JM, Kaplan, Love B, Kohli N, Albala D,

Shingleton B. Transvaginal radiofrequency treatment of the endopelvic fascia: A prospective evaluation for the treatment of genuine stress urinary incontinence. J Urol 169; 1028 -1032, 2003.

73. Gomelsky A, Dmochowski RR. Incisional bladder hernia after rectus fascial sling. J Urol 169;

2299-2230, 2003.

13

74. Hassan M, Gomelsky A, Dmochowski RR. Artificial urinary sphincter migration causing obstructive renal failure in a solitary kidney. J Urol 170; 2003.

75. Gomelsky A, Lemack G, Weld K, Dmochowski R. Urodynamic patterns following ischemic

spinal cord events. J Urol 170;122- 125, 2003. 76. Diokno A, Appell R, Sand P, Dmochowski RR, Gburek B, Klimberg I. A prospective,

randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine in overactive bladder: results of the OPERA trial. Mayo Clin Proc 78; 2003.

77. Dmochowski R, Sand P, Zinner NR, Gittleman M, Davila GW, Sanders S. Comparative

safety and efficacy of transdermal oxybutynin versus tolterodine in previously treated patients with urge and mixed urinary incontinence. Urology 62; 237 -242, 2003.

78. Gomelsky A, Nitti VW, Dmochowski RR. Management of obstructive voiding dysfunction

after incontinence surgery: lessons learned. Urol 62(3); 391 -399, 2003. 79. Dmochowski R, Miklos J, Norton PA, Zinner NR, Yalcin I, Bump R. Duloxitene vs. Placebo

in the treatment of North American women with stress urinary incontinence. J Urol 170(4); 1259 -1263, 2003.

80. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A,

Sharlip ID. American Urologic Association Guideline on the Management of Priapism. J Urol 170(4); 1318 -1324, 2003.

81. Cole E, Gomelsky A, Dmochowski RR. Encapsulation of a porcine dermis pubovaginal sling.

J Urol 170(50); 1950, 2003. 82. Dmochowski R, Appell RA. Advancements in minimally invasive treatments for stress

urinary incontinence. Curr Urol Rep 4(5); 350-355, 2003. 83. Scarpero HS, Dmochowski RR. Muscarinic receptors and the urinary bladder. Curr Urol Rep

4(6); 421-428, 2004. 84. Gomelsky A, Rudy DC, Dmochowski.RR. Repair of high grade anterior compartment defects

with porcine dermis interposition graft. J Urol. 171(4); 1581-1584,2004. 85. Sathyan G, Dmochowski R, Appell R, Guo C, Gupta S. Effect of antacid on the

pharmacokinetics of extended release tolterodine and oxybutynin. Clin Pharmacokinet 43 (13); 1059- 1068, 2004.

86. Scarpero H, Dmochowski R. Sling Failures: What’s Next. Curr Urol Rep 5; 389 -396, 2004. 87. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A,

Sharlip ID. American Urologic Association Guideline on the Management of Premature Ejaculation. J Urol 170(4); 1318 -1324, 2004.

14

88. Zinner N, Harnett M, Sabounjian L, Sandage B, Dmochowski R, Staskin D. The overactive bladder-symptom composite score: A composite symptom score of toilet voids, urgency severity, and urge urinary incontinence in patients with overactive bladder. J Urol 173; 1639 -1643, 2005.

89. Chu F, Dmochowski R, Lama D, Anderson R, Sand P. Extended release formulations of

oxybutynin and tolterodine exhibit similar central nervous system profiles: A subanalysis of data from the OPERA trial. Am J Ob Gyn 192; 1849-1855, 2005.

90. Dmochowski R, Chen A, Sathyan G, MacDiarmid S, Gidwani S, Gupta S. Effect of the proton

pump inhibitor omeprazole on the pharmacokinetics of extended – release formulations of oxybutynin and tolterodine. J Clin Pharm45; 1-7, 2005.

91. Dmochowski R. Improving the tolerability of anticholinergic agents in the treatment of

overactive bladder. Drug Safety. 28(7):583-600, 2005. 92. Dmochowski R. Urinary frequency: event measure, outcome significance?

Curr Urol Rep 6(2):87-8, 2005. 93. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Milbank A,

Nehra A, Sharlip ID. The management of erectile dysfunction: an AUA update. J Urol. 174(1):230-9, 2005.

94. Cole E, Dmochowski R. Office Urodynamics. Urol Clin NA. 32:3, 353 -370,2005 95. Dmochowski RR, Sanders S, Appell RA, Nitti V, Davila GW. Bladder Health Diaries: An

assessment of three-day versus seven-day entries. BJUI 96; 1049-1054, 2005. 96. Cole E, Scarpero H, Dmochowski R. Are patient symptoms predictive of the diagnostic and /

or therapeutic value of hydrodistention? Neurourol Urodyn. 24;638-642,.2005.

97. Dmochowski R, Staskin D. The Q-T Interval and Antimuscarinic Drugs. Curr Urol Rep. 2005 Nov;6(6):405-9.

98. MacDiarmid S, Dmochowski R, Anderson R. Dose escalation of Ditropan XL. J Urol 174; 1301-1305, 2005.

99. Dmochowski R, Nitti V, Staskin D, Luber K, Appell R, Davila GW. Transdermal Oxybutynin in the Treatment of Adults With Overactive Bladder: Combined Results of Two Randomized Clinical Trials. W J Urol 23(4); 263-270, 2005

100. Cole E, Scarpero H, Gomelsky A, Dmochowski R. Histopathological Evaluation of the Uterosacral Ligament: Is This a Dependable Structure for Pelvic Reconstruction? BJU Int 97(2); 345-348, 2006

101. Rudy DR, Cline K, Harris R, Goldberg K, Dmochowski R.Time to Onset of Improvement in Symptoms of Overactive Bladder Using Antimuscarinic Treatment. BJUI Int 97(3); 540 -546, 2005

102. Chapple C, Wein AJ, Brubaker L, Dmochowski R, Espuna Pons M, Haab F, Hill S. Stress incontinence injection therapy: What is best for our patients? Eur Urol 48(4); 552-565, 2005.

103. Chu FM, Dmochowski RR. Pathophysiology of overactive bladder. Am J Med 119 (3 S1); 3- 8, 2006.

15

104. Lavelle JP, Karram M, Chu FM, Dmochowski RR, MacDiarmid SA, Staskin DR, Sand PK. Management of incontinence for family practice physicians. Am J Med 119 (3 S 1); 37 – 40, 2006.

105. Rudy D, Cline K, Harris R, Goldberg K, Dmochowski R. A Multicenter Phase III Trial Studying Trospium Chloride in Patients with Overactive Bladder. Urol 67(2); 275 – 280, 2006.

106. Nitti V, Dmochowski R, Appell RA, Wang J, Bavendam T, Guan Z. Efficacy and Tolerability of Tolterodine Extended Release in Continent Patients With Overactive Bladder and Nocturia BJU Int 97; 1262- 1266, 2006.

107. Cole EE, Kaufman, M, Scarpero, H, Dmochowski RR. The effects of isolated posterior compartment defects on lower urinary tract symptoms and urodynamic findings. BJU Int. 97:1024- 1026, 2006.

108. Nitti V, Sanders S, Staskin D, Dmochowski R, Sand PK, MacDiarmid S, Maibach H. Transdermal Delivery of drugs for urologic applications: Basic principles and applications. Urol 67(40); 657-664, 2006

109. Abrams P, Artibani W, Cardozo L, Dmochowski R, van Kerrobroeck P, Sand Peter. Reviewing the ICS 2002 Terminology report: The ongoing debate. Neurourol Urodyn 25; 293, 2006.

110. Kaplan SA, Roehrborn CG, Dmochowski R, Rovner E , Wang JT, Guan E. Tolterodine Extended Release Improves Overactive Bladder Symptoms in Men With Overactive Bladder and Nocturia. Urol 68: 328 -332, 2006.

111. Dmochowski RR. The puzzle of the overactive bladder: controversies, inconsistencies, and insights. Int Urogynecol J. 17; 650 -658, 2006.

112. Dmochowski R, Starkman J, Davila W. Transdermal drug delivery treatment for overactive bladder. Int Braz J Urol. 2006 Sep-Oct;32(5):513-20

113. Starkman JS, Scarpero H, Dmochowski RR. Voiding dysfunction associated with eroded vaginal slings. J Urol;176(6 Pt 1):2749, 2006. Starkman JS, Scarpero H, Dmochowski RR. Transdermal oxybutynin. Urol Clin North Am. 2006 Nov;33(4):455-63

114. Dmochowski R, Sand P. Botulinum toxin A in the overactive bladder; current status and future directions. BJUI 99; 247 -262, 2007.

115. Dmochowski R. Overactive bladder pharmacotherapy: what does the future hold? BJU Int. 2007 Jun;99 Suppl 3:13-6.

116. Dmochowski R, Newman D. Impact of overactive bladder on women in the United States: results of a national survey. Curr Med Res Opin 23 (1); 65-76, 2007.

117. Sand P, Zinner N, Newman D, Lucednte V, Dmochowski R, Kelleher C, Dahl N. Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study.BJU Int;99(4):836-44, 2007.

118. Staskin D, Sand P, Zinner N, Dmochowski R. Once Daily Trospium Chloride is Effective and Well Tolerated for the Treatment of Overactive Bladder: Results From a Multicenter Phase III Trial..J Urol. ;178(3):978-84, 2007.

119. Nitti V, Dmochowski R, Sand P, Forst HT, Haag- Molkenteller C, Massow U, Wang J, Brodsky M, Bavendam T. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome. J Urol. 178(6):2488-94, 2007.

120. Gomelsky A, Dmochowski R. Biocompatibility assessment of synthetic sling materials for female stress urinary incontinence. J Urol. 2007;178(4 Pt 1):1171-81. 2007.

121. Starkman J, Dmochowski R. Urgency Assessment in the Evaluation of Overactive Bladder (OAB). Neurourol Urodyn. 2007 Jul 31; Epub.

122. Starkman JS, Scarpero H, Milam D, Dmochowski RR. Sacral neuromodulation for refractory voiding dysfunction after urogynecologic surgery. Neurourol and Urodyn ;26(1):29-32, 2007.

16

123. Starkman JS, Duffy J, Wolter C, Kaufman M. Scarpero H, Dmochowski RR Refractory overactive bladder after urethrolysis for bladder outlet obstruction: management with sacral neuromodulation. Int Urogynecol J Pelvic Floor Dysfunct. 2007 Aug 2; [Epub ahead of print]

124. Staskin D, Sand P, Zinner N, Dmochowski R. Once-daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial. J Urol 178(3 Pt 1):978-83, 2007.

125. Burnett A, Thompson I, Thrasher B, Aus G, Burnett A, Canby-Higino E, Cookson M, D’Amico A, Dmochowski R, Eton D, Forman J, Goldenberg L, Hernandez J, Higano C, Kraus S, Moul J, Tangen C. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol. 2007;178(2):597-601.

126. Dmochowski R, Kreder K, MacDiarmid S, Carlsson M, Guan E. The clinical efficacy of tolterodine extended-release is maintained for 24 h in patients with overactive bladder.BJU Int. 2007;100(1):107-10.

127. Thompson I, Thrasher B, Aus G, Burnett A, Canby-Higino E, Cookson M, D’Amico A, Dmochowski R, Eton D, Forman J, Goldenberg L, Hernandez J, Higano C, Kraus S, Moul J, Tangen C. Clinically localized prostate cancer: 2007 update. J Urol;177 (6):2106-31, 2007.

128. Mayer RD, Dmochowski R, Appell RA, Sand PK, Klimberg I, Jacoby K, Graham CW, Snyder JA, Nitti V, Winters JC. Multicenter Prospective Randomized 52-Week Trial of Calcium Hydroxylapatite vs. Bovine Dermal Collagen for Treatment of Stress Urinary Incontinence. Urol;69(5):876-80, 2007.

129. Seif C, Boy S, Wefer B, Dmochowski R, Braun PM, Junemann KP. Botulinum toxin for the treatment of overactive bladder - an overview.]Urologe A. 2007 Nov 24; [Epub ahead of print] German

130. Armstrong RB, Dmochowski RR, Sand P, MacDiarmid S. Safety and tolerability of extended release oxybutynin once daily in urinary incontinence: Combined result from two pahse 4 controlled clinical trials. Int Urol and Nephrol. 2007 Mar 2; [Epub ahead of print]

131. Cookson M, Thompson I, Thrasher B, Aus G, Burnett A, Canby-Higino E, D’Amico A, Dmochowski R, Eton D, Forman J, Goldenberg L, Hernandez J, Higano C, Kraus S, Moul J, Tangen C. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol;177(2):540-5, 2007.

132. Khullar V, Rovner ES, Dmochowski R, Nitti V, Wang J, Guan Z.Fesoterodine dose response in subjects with overactive bladder syndrome. Urology. 2008 May;71(5):839-43

133. Dmochowski R, Marschall Kehrel D, Hussain I, Wang J, Guan Z, Abrams P. Efficacy and Tolerability of Tolterodine Extended Release in Male and Female Patients With Overactive Bladder and Nocturia. Eur Urol 51; 1054 -1064, 2007.

134. Martinez-Ferrer M, Iturregui J, Uwamanira C, Starkman J, Sharif-Afshar A, Suzuki K, Matuszik R, Dmochowski R, Bhowmick N. Role of Nicotinic and Estrogen Signaling during Experimental Acute and Chronic Bladder Inflammation. Am J Path 172; 1-9, 2008.

135. Woodruff A, Beckman E, Cole E, Dmochowski R, Winters JC. A Histological Comparison of Pubovaginal Sling Graft Materials: A Comparative Study. Urology. 72(1):85-90, 2008.

136. Wolf JS, Bennett C, Dmochowski R, Hollenback B, Pearle M, Schaeffer A. Best Practice Policy Statement on Urologic Surgery Antimicrobial Prophylaxis. J Urol 179; 1379-1390, 2008.

137. Wolter C, Starkman J, Scarpero H, Dmochowski R. Removal of transobturator midurethral sling for refractory thigh pain. Urology. 72(2):461 2008.

http://www.ncbi.nlm.nih.gov/pubmed/18342923?ordinalpos=17&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum


17

138. Chapple CR, Wein A, Abrams P, Dmochowski R, Giuliano F, Kaplan S, McVary K, Roehrborn CG. Lower Urinary Tract Symptoms Revisited: A Broader Clinical Perspective. Eur Urol 54; 263 -269, 2008.

139. Starkman, J, Martinez-Ferrer M, Iturregui J, Uwamariya C, Dmochowski R, Bhowmick N. Nicotinic signaling amerliorates acute bladder inflammation induced by protamine sulfate or cyclophosphamide. J Urol. 179(6):2440-6. 2008.

140. Dmochowski RR, Sand PK, Zinner NR, Staskin DR.Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study. Urology. 2008 Mar;71(3):449-54

141. Dmochowski R, Fitzpatrick JM.The evidence basis of urology: in pursuit of 'the right stuff'. BJU Int. 2008 Sep;102(6):1-3

142. Kaufman MR, Scarpero H, Dmochowski RR.Diagnosis and management of outlet obstruction in the female. Curr Opin Urol. 2008 Jul;18(4):365-9.

143. Hubbard H, Kosiak B, Dmochowski R, Faraday M. Staying at the cutting edge: a review and analysis of evidence reporting and grading; the recommendations of the American Urological Association. BJUI BJU Int. 2009 Aug;104(3):294-7.

144. Abrams P, Artibani W, Cardozo L, Dmochowski R, van Kerrebroeck P, Sand P; International Continence Society. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn. 2009;28(4):287.

145. Sand PK, Steers WD, Dmochowski R, Andoh M, Forero-Schwanhaeuser S.Patient-reported most bothersome symptoms in OAB: post hoc analysis of data from a large, open-label trial of solifenacin.. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jun;20(6):667-75.

146. Hanno P, Dmochowski R. Status Of International Consensus On Interstitial Cystitis / Bladder Pain Syndrome / Painful bladder Syndrom: 2008 Snapshot. Neurourol Urodyn. 2009;28(4):274-86

147. Staskin, Dr, Dmochowski R, Sand P, MacDiarmid S, Caramelli K, Thomas H, Hoel G. Efficacy and Safety of Oxybutynin Chloride Topical Gel for Treatment of Adults With Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study. J Urol J Urol. 2009 Apr;181(4):1764-72

148. Lewis A, Kaufman M, Wolter C, Phillips S, Maggi D, Condry L, Dmochowski RR., Smith J. Vesicovaginal Fistula Experience in Sierra Leone: Review of 505 Cases. J Urol J Urol. 2009 Apr;181(4):1725-31

PUBLICATIONS IN PRESS:

1. Scarpero H, Kaufman M, Koski M, Dmochowski R. Urodynamics Best Practices. AUA

Update Series, 2009 (in press). 2. Kaufman M, Scarpero H, Dmochowski R. Assessing Outcomes of Stress Urinary

Incontinence Surgery in Women. AUA Update Series, 2009 (in press). 3. Kaufman, M.R., Scarpero, H.S., and R.R. Dmochowski (2009). Stress urinary incontinence

surgery at the time of prolapse repair. W Jour Urol 4. Wolter, C.E., Kaufman, M.R., Duffy, J.W., Scarpero, H.M., and R.R. Dmochowski (2009)

Mixed incontinence and cystocele: Changes seen after anterior compartment repair and pubovaginal sling not predicted by preoperative urodynamics. Int Urogyn Jour.

5. Kaufman, M.R., Scarpero, H.S., and R.R. Dmochowski (2009) Painful Bladder Syndrome: Is Consensus Possible? Curr Blad Dysfun Reports. 4 (2): 86-90.









18

6. Stec, A.A., Stratton, K.L., Kaufman, M.R., Chang, S.S., Milam, D.F., Herrell, S.D., Dmochowski, R.R., Smith, J.A., Jr., Clark, P.E., and M. S. Cookson (2009) Operative renal biopsy: Comorbidities and complications in a contemporary series. BJU Intl.

7. Kraus S, Dmochowski R, Albo M, Lu X, Klise S, Roehrborn C. Urodynamic standardization in a large scale, multicenter clinical trial examining the effects of daily tadalafil in men with lower urinary tract symptoms with or without benign prostatic obstruction. Neurourol Urodyn (in press)

8. Sand P, DmochowskiR, Zinner N, Staskin D. Trospium Chloride Extended Release Is Effective and Well Tolerated in Women With Overactive Bladder Syndrome. Int Urogyn J (in press)

9. Dmochowski R, Fitzgerald MP, Wyndaele JJ. Measuring Urgency in Clinical Practice. WJU in press).

Other Articles

1. Dmochowski RR. Evaluating the effectiveness of therapies for urinary incontinence. Rev in Urol. 3; 7 – 14, 2001.

2. Dmochowski RR: Recognition and treatment of the overactive bladder. Family Practice Recertification. 23: 19 –30, 2001.

3. Dmochowski RR: Interventions for detrusor overactivity. The case for multimodal therapy. Rev In Urol 4; 2002.

4. Gomelsky A, Dmochowski RR. Antibiotic Prophylaxis in urologic surgery. Infections in Medicine. Current Pharmaceutical Design. 9, 2003 (in press).

5 Gomelsky A, Scarpero H, Dmochowski RR. Sling procedures: What material? What Choice?. AUA Updates (in press).

6 Dmochowski RR. Recent Comparator Trials in Overactive Bladder. The Female Patient, 2003.

7 Leu P, Dmochowski RR. Overactive bladder: Current understanding and medical treatment. Am J Urol. 2003.

8 Dmochowski RR. Treatment of the Overactive bladder: Where we stand in 2003. Rev in Urol, 2003.

9 Dmochowski RR. Duloxitene: A review of the current clinical data, Rev. in Urol, 2003. 10 Rosenberg ME, Dmochowski RR. Overactive Bladder: Evaluation and management in

primary care. Clev Clin Jnl Med 72(2); 149 -156, 2004 11 Dmochowski R, Staskin D. Mixed urinary incontinence. Curr Opin in Urol. 2005 (in press) 12 Dmochowski R. Bladder outlet obstruction: etiology and evaluation.Rev Urol. 2005 13 Dmochowski R. Antimuscarinic therapy in men with lower urinary tract symptoms: what is

the evidence? Curr Urol Rep. 2006 Nov;7(6):462-7 14 Starkman JS, Scarpero HS, Dmochowski R. Emerging Periurethral Bulking Agents for

Female SUI: Is New Necessarily Better? Rev in Urol (in press) 15 Dmochowski R . Mid-urethral slings: surgical evolution as manifest by technology.Nat Clin

Pract Urol. 2007 May;4(5):242-3. 16 DmochowskiRR, Larson-Peters, AEfficacy of Darifenacin in Patients with Varying Baseline

Symptom Severity. UroToday International Journal. 2009 17 Gomelsky A, Dmochowski R. Overactive bladder in males. Therapeutic Advances in Urology

(in press) 18 Dmochowski R, Rosenberg M, Zinner N, Sand P, Staskin D. Extended-Release Trospium

Chloride Improves Quality of Life in Overactive Bladder. Value in Health (in press) VIDEOTAPES/CD ROMS/INTERNET

19

1. Leach G.E., Ganabathi K., Sirls L, Dmochowski R.: Visual Laser Assisted Prostatectomy. 1993.

2. Leach G.E., Blaivas, J.G., Dmochowski, R.: Periurethral Fat Injection. 1993. 3. Zimmern P.E., Leach G.E., Dmochowski R.: Transvaginal Rectocele and Perineum Repair.

1994. 4. Dmochowski R.: Female Stress Urinary Incontinence. Patient Management Problem, A.U.A.

CD ROM Series. 1997. 5. Dmochowski R: Contemporary Urologic Use of the Pessary. 1998. 6. Dmochowski RR: A Man with Lower Urinary Tract Symptoms. Patient Management

Problem, A.U.A. CD ROM Series. 1999. 7. Dmochowski RR: A woman with unwanted urinary loss after hysterectomy. Patient

Management Problem, A.U.A. CD ROM Series. 2000. 8. Winters JC, Dmochowski RR: A woman with frequency and urgency. Patient Management

Problem, A.U.A. CD ROM Series. 2001. 9. Gomelsky A, Dmochowski R. Surgery for Stress Incontinence. Timely Topics in Medicine.

Prous Science. 2002 ABSTRACTS PRESENTED: 1. Lewis R., Fried T., Dmochowski R., Janney R., Van Buren C., Kahan B., and Corriere J.N.,

Jr.: Endogenous Atrial Natriuretic Factor (ANF) Levels Do Not Predict Rate of Recovery of Allograft Function Following Primary Cadaveric Renal Transplantation Poster Presentation at the Annual Meeting of the American Urologic Association, Dallas, TX, May, 1988.

2. Dmochowski R.R., Rudy D. C., Weitzner S., and Corriere J. N., Jr.: Simple Cyst of the Testis.

Podium Presentation at the Annual Meeting of the Texas Medical Association, Fort Worth, Texas. May1989.

3. Coddington C., Dmochowski R., Franken D., Burkman L., Hodgen G.: Hemizona Assay Can

Be Used To Evaluate Fertility Potential After Vasectomy Reversal. Podium Presentation at American College of Obstetricians and Gynecologists Armed Forces District, Reno, Nevada. Oct.1990.

4. Bildsten Scott, Dmochowski R., Auman J.: The Impact of Surgery on Chronic Scrotal Pain.

Podium Presentation at Society of Government Service Urologists Annual Meeting, Baltimore, Md. Dec.1991.

5. Weisner B., Dmochowski R., Auman J.: Renal Artery Embolic Disease. Poster Presentation at

Society of Government Service Urologists Annual Meeting, Baltimore, Md. Dec.1991.

6. Ronningen L.,Dmochowski R., Auman J.: Traumatic Intra-corporal Laceration Presenting as Perineal Mass, Poster Presentation at Society of Government Service Urologists Annual Meeting, Baltimore, Md. Dec.1991.

7. Stoioff Scott, Dmochowski R., Auman J.: Leiomyosarcoma of the Spermatic Cord Occurring

After Radiation Therapy for Carcinoma of the Prostate. Poster presentation at Society of Government Service Urologists Annual Meeting, Baltimore, Md. Dec.1991.

20

8. Vukovich J., Dmochowski R., Auman J., Coddington C.: The Use of Hemizona Analysis in the Evaluation of Fertility Potential. Poster presentation at the Society of Government Service Urologists Annual Meeting Baltimore, Md. Dec.1991.

9. Bildsten S., Dmochowski R., Auman J.R.: Rhabdomyolysis and Prolonged Lithotomy

Position. Podium presentation Society of Government Service Urologists Annual Meeting, Seattle, Wa. Dec., 1992.

10. McKenna P., Dm0chowski R.: Bladder Augmentation with Ureter. Podium Presentation,

Society of Government Service Urologists Annual Meeting, Seattle, Wa. Dec.1992. 11. Dmochowski R., Ganabathi K., Leach G.: Periurethral Fat Injection. Postgraduate Course,

Western Section American Urologic Association, Palm Desert, Ca. Nov. 1993. 12. Dmochowski R., Ganabathi K., Sirs L., Zimmern P.E., Leach G.E.: A Critical

Appraisal of Management of Peyronie's Disease: Plaque Incision and Synthetic Grafting in Potent Men. Podium Presentation, Western Section American Urologic Association, Palm Desert, Ca. Nov.1993.

13. Sirls L., Dmochowski R., Zimmern P.E., Ganabathi K., Kaswick J., Leach G.E.: The Studer

Neobladder: A Videourodynamic Evaluation Podium Presentation, Western Section American Urologic Association, Palm Desert, Ca. Nov.1993.

14. Sirls L., Dmochowski R., Ganabathi K., Zimmern P.E., Leach G.E.: Comparison of

Abdominal Fascia and Fascia Lata Pubovaginal Sling For Type III Stress Urinary Incontinence: Emphasis on Patient Satisfaction. Poster Presentation, Western Section American Urologic Association, Palm Desert, Ca. Nov.1993.

15. Sirls L., Dmochowski R., Zimmern P.E., Ganabathi K., Leach G.E.: Comparison of

Periurethral Teflon Injection For Female Type II and Type III Stress Urinary incontinence. Poster Presentation, Western Section American Urologic Association, Palm Desert, Ca. Nov.1993.

16. Dmochowski R., Csiszar J., Ganabathi K., Leach G.: Periurethral Fat Injection: A Novel

Technique for Stress Urinary incontinence. Podium Presentation, American College of Surgeons, Southern Cal. Chapter, Newport Beach, Ca. Jan. 1994.

17. Csiszar J., Dmochowski R., Leach G.E.: Malignant Melanoma of the Female Urethra.

Podium Presentation, American College of Surgeons, Southern California Chapter, Newport Beach, Ca, Jan.1994.

18. Gerspach J., Dmochowski R., Zimmern P.E.: The Studer Neobladder: A Videourodynamic

Evaluation. Podium Presentation American College of Surgeons, Southern California Chapter, Newport Beeach, Ca. Jan.1994.

19. Ganabathi K., Dmcchowski R., Zimmern P.E., Leach G.E.: Clinical Presentation of

63 Cases of Female Urethral Diverticulum. A.U.A. Annual Meeting, San Francisco, Ca. May 1994.

21

20. Dmochowski R., Leach G.E., Zimmern P.E., Roskamp D.,Ganabathi K.: Urethrolysis to Relieve Bladder Outlet Obstruction After Prior Incontinence Surgery. A.U.A. Annual Meeting, San Francisco, Ca. May 1994.

21. Dmochowski R., Roskamp D., Zimmern P.E., Ganabathi K., Leach G.E.: Variability of

Valsalva Leak Point Pressure with Bladder Volume. A.U.A. Annual Meeting, San Francisco, Ca. May 1994.

22. Hernandez R., Dmcchowski R., Leach G.E., Zimmern P.E.: Moderate Cystocele Causing

Bladder Outlet Obstruction. A.U.A. Annual Meeting, San Francisco, Ca. May 1994. 23. Blaivas J., Heritz D., Leach G.E., Dmochowski R., Ganabathi K.: Periurethral Fat Injection

for Sphincteric incontinence. A.U.A. Annual Meeting, San Francisco, Ca. May 1994. 24. Zimmern P.E., Ganabathi K., Dmochowski R., Leach G.E.: Five Year Experience with

Transvaginal Repair of Vaginal Vault Prolapse and Prevention of Enterocele Recurrence by High Midline Levator Myorraphy. A.U.A. Annual Meeting, San Francisco, Ca. May 1994.

25. Leach G.E., Dmochowski R., Ganabathi K., Broderick G.A., Wein A.J., Cowles R.S.,

Kabalin J.N., Gill H.S.: Visual Laser Assisted Prostatectomy (VLAP) Using Right Angle Fiber: Results of 60 Watt Protocol. A.U.A. Annual Meeting, San Francisco, Ca. May 1994.

26. Leach G.E., Sirs L., Dmochowski R., Ganabathi P.E., Zimmern P.E.: Visual Laser

Prostatectomy with Local Anesthesia. (Video) A.U.A. Annual Meeting, San Francisco, Ca. May 1994.

27. Dmochowski R., Leach G.E.: Pelvic Prolapse and the Evaluation of Female Urinary

Incontinence. Post Graduate Course. A.U.A. Annual Meeting, San Francisco, Ca. May 1994. 28. Leach G.E., Dmochowski R., Ganabathi K.: Periurethral Fat Injection. Society of Urologic

Engineering. A.U.A. Annual Meeting, San Francisco, Ca. May 1994. 29. Dmochowski R., Ganabathi K., Leach G.E.: Non-operative Management of Spinal Cord

Injury. Urodynamics Society. San Francisco, CA. May 1994. 30. Ganabathi K., Dmochowski R., Zimmern P.E., Leach G.E.: Clinical Presentation of

63 Cases of Female Urethral Diverticulum. A.U.A. Western Section Meeting, Seattle, Wa. Sept.1994.

31. Dmochowski R., Leach G.E., Zimmern P.E., Roskamp D.,Ganabathi, K.:

Urethrolysis to Relieve Bladder Outlet Obstruction After Prior Incontinence Surgery. A.U.A. Western Section Meeting. Sept.1994.

32. Dmochowski R., Roskamp D., Zimmern P.E., Ganabathi K., Leach G.E.: Variability of

Valsalva Leak Point Pressure with Bladder Volume. A.U.A. Western Section Meeting, Seattle Wa. Sept.1994.

33. Trockman B., Omochowski R., Ganabathi K., Leach G.E.: Periurethral Fat Injection for

Sphincteric Incontinence. A.U.A. Western Section Meeting, Seattle Wa. Sept. 1994.

22

34. Zimmern P.E., Ganabathi K., Dmochowski R., Leach G.E.: Five Year Experience with

Transvaginal Repair of Vaginal Vault Prolapse and Prevention of Enterocele Recurrence by High Midline Levator Myorraphy. A.U.A. Western Section Meeting, Seattle Wa. Sept.1994.

35. Leach G.E., Drnochowski R., Ganabathi K., Broderick G.A., Wein A.J., Cowles R.S.,

Kabalin J.N., Gill H.S.: Visual Laser Assisted Prostatectomy (VLAP) Using Right Angle Fiber: Results of 60 Watt Protocol. A.U.A. Western Section Meeting, Seattle Wa. Sept.1994.

36. Dmochowski R., Irockman B., Ganabathi K., Leach G.E.: Non-Operative Management of

Spinal Cord Injury: Long Term Follow Up. A.U.A. Western Section Meeting, Seattle, Wa. Sept.1994.

37. Dmochowski R., Trockman B., Ganabathi K., Leach G.E.: Visual Laser Prostatectomy

(VLAP): One Year Follow Up With Pressure Flow Evaluation. A.U.A. Western Section Meeting, Seattle Wa. Sept.1994.

38. Leach G.E., Blaivas J.G., and Dmochowski R.: Periurethral Fat Injection. Film. A.U.A.

Western Section, Seattle, Wa. Sept.1994. 39. Csiszar J., Dmochowski R., and Leach G.E.: Malignant Melanoma of the Female Urethra.

A.U.A. Western Section, Seattle, Wa. Sept.1994. 40. Zimmern P.E., Ganabathi K., Dmochowski R., Leach G.E.: Five Years Experience with

Transvaginal Repair of Vaginal Vault Prolapse and Prevention of Enterocele Recurrence By High Midline Levator Myorraphy. Podium Presentation, Society of International Urology, Sydney, Australia. Oct.1994.

41. Leach G.E., Zimmern P.E., Ganabathi K., Dmochowski R., Kaswick, J.: A Prospective

Evaluation of Potency Following Nerve Sparing Radical Prostatectomy. Podium Presentation, Society of International Urology, Sydney, Australia. Oct. 1 994.

42. Zimmern P.E., Dmochowski R., Sirls L. Ganabathi K., Leach G.E., Kaswick J.:

Vidoeurodynamic Evaluation of the Studer Neobladder. Podium Presentation, Society of International Urology, Sydney, Australia. Oct.1994.

43. Kneib, T.A., Dmochowski, R., Patterson, A.L. and Cox, C.E.: Major Renal Laceration after

Blunt Abdominal Trauma Comparison between Expectant Management versus Early Surgical Intervention. Podium Presentation, Southeastern Section American Urological Association, Florida, April 1995.

44. Stonehill, W., Dmochowski, R., Patterscn, A.L. and Cox, C.E.: Risk Factors for

Development of Bladder Tumors in Spinal Cord Injury Patients. Podium Presentation, Southeastern Section American Urological Association, Lake Buena Vista, Florida, April 1 995.

23

45. Dmochowski, R., Ganabathi, K., Sirls, L., Zimmern, P.E., and Leach, G.E.: Long-term Appraisal of Four Corner Bladder Neck Suspension. Poster Presentation, American Urological Association, Las Vegas, Nevada, April 1995.

46. Dmochowski, R., Ganabathi, K., Zimmern, P.E. and Leach, G.E.: Coaxial Needle

Electromyography As An Adjunct To Cinical Neurourologic Testing. Poster Presentation, American Urological Association, Las Vegas, Nevada, April 1995.

47. Stonehill, W., Dmochowski, R., Patterscn, A.L. and Ccx, C.E.: Risk Factors for

Development of Bladder Tumors in Spinal Cord Injury Patients. Poster Presentation, American Urological Association, Las Vegas, Nevada, April 1995.

48. Goldman, H., Dmochowski, R., and Cox, C.E.: Penetrating Penile Trauma and Evaluation of

Cosmetic and Functional Results. Foster Presentation, American Urological Association, Las Vegas, Nevada, April 1995.

49. Dmochowski, R., Ganabathi, K., Sins, L., Zimmern, P.E., and Leach, G.E.: Long-term

Appraisal of Four Corner Bladder Neck Suspension. Podium Presentation, Urodynamics Society, Las Vegas, Nevada, April 1995.

50. Dmochowski R., Littlejohn J., Cox C.E., Amiri H., Hathaway D., Gaber, O.: Stability of

Bladder Function Two Years Following Simultaneous Pancreas-Kidney Transplantation. Podium Presentation, International Society of Pancreatic Transplantation. Miami, Fl. June, 1995.

51. Dmochowski R., Littlejohn J., Amiri H., Gaber 0.: Urodynamic Assessment of Bladder

Function after Pancreas-Kidney Transplantation. Foster Presentation, South Central Section A.U.A., Sept.1995.

52. Goldman H., Dmochowski R.: Urodynamic findings in Diabetic and Non-diabetic

Gastroparesis. Poster Presentation, International Bladder Symposium, Boston, Ma., Mar.1996.

53. Stonehill W., Van Bingham W., Dmochowski R: The value of cytology in screening spinal

cord injured patients with indwelling catheters. Poster Presentation, International Bladder Symposium, Boston, Ma., Mar.1996.

54. Hollabaugh R., Dmochowski R., Steiner M.: The neuroanatomy of the male sphincteric

mechanism. Poster Presentation, Poster Presentation, International ladder Symposium, Boston, Ma., Mar .1 996.

55. Howard R., Hollabaugh R., Dmochowski R.: Long term urodynamic evaluation of patients

with cyclophosphamide cystitis. Poster Presentation, International Bladder Symposium, Boston, Ma., Mar.1996.

56. Hollabaugh R., Dmochowski R., Cox C.E.: Fournier's Ganarene: Clinical Implications.

Podium Presentation, Southeastern Section A.U.A., Puerto Rico, April, 1996.

24

57. Dmochowski R., Littlejohn J., Amiri H., Gaber 0.: Urodynamic Assessment of Bladder Function after Pancreas-Kidney Transplantation. Podium Presentation, Southeastern Section A.U.A., Puerto Rico, April 1996.

58. Hollabaugh R., Dmochowski R., Steiner M.: In Search of the Urinary Continence Nerves.

Podium Presentation, Southeastern Section A.U.A., Puerto Rico, April 1996. 59. Kneib T., Dmochowski R.: Gunshot wounds to the Posterior Urethra. Podium Presentation,

Southeastern Section A.U.A., Puerto Rico, April 1996. 60. Goldman H., Dmochowski R.: Urodynamic findings in Diabetic and Non-diabetic

Gastroparesis. Podium Presentation, Southeastern Section A.U.A., Puerto Rico, April 1996.

61. Samm William, Dmochowski R, Jerkins G: Case of Mullerian Duct Cyst with Associated

Blind Ending Ureterocele and Ipsilateral Renal Agenesis in a Newborn. Podium Presentation, Southeastern Section - A.U.A., Puerto Rico, April 1996.

62. Stonehill W., Van Bingham W., Dmochowski R: The value of cytology in screening spinal

cord injured patients with indwelling catheters. Poster Presentation, American Urologic Association Annual Meeting, Orlando Fla. May, 1996.


mechanism. Poster Presentation, American Urologic Association Annual Meeting, Orlando Fla. May, 1996.

64. Jo P., Gavant M., Dmochowski R.: The accuracy of CT cystography in the evaluation of

traumatic bladder injury. Poster Presentation, American Urologic Association Annual Meeting, Orlando Pa. May, 1996.


mechanism. Podium Presentation, Urodynamic Society Annual Meeting, Orlando Fia. May, 1996.

66. Idom BA, Goldman H, Dmochowski R.: Increasing Incidence of Male External Genitalia

Trauma. Podium Presentation, Southeastern Section A.U.A., Naples, Fl., Mar., 1997. 67. Hollabaugh R, Dmochowski R, Steiner MS. : Surgical Modifications for Radical

Retropubic Prostatectomy. Poster Presentation, Southeastern Section A.U.A., Naples, Fl. Mar., 1997.

68. Hollabaugh R. Steiner MS, Dmochowski RR: Neuroanatomy of the Female Continence

Nerves. Podium Presentation, Southeastern Section A.U.A., Naples, Fl. ,Mar., 1997. 69. Gubin D., Wake R., Dmochowski RR: Laparoscopic Orchiectomy. Podium Presentation,

Southeastern Section A.U.A., Naples, Fl. Mar., 1997. 70. Siddique NJ, D'Alessio JG, Dmochowski RR: A Comparative Study of Topical Eutectic

Mixture of Local Anesthetics (EMLA) Cream and Dorsal Nerve Block for Circumcision in

25

Adult Males. Poster Presentation. American Society of Regional Anesthesia. Atlanta, Ga. April 1997.

71. Leungwattanakij S, Muangman V, Kochakarn W, Choonhaklai V, Dmochowski R:

Traumatic Testicular Dislocation. Podium Presentation. American Urologic Association Annual Meeting. New Orleans, Louisiana, April, 1997.

72. Goldman H, Idom C, Dmochowski R: Traumatic Injury to the Female Genitalia. Podium

Presentation. American Urologic Association Annual Meeting. New Orleans, Louisiana, April, 1997.

73. Delnay K, Stonehill W, Goldman H, Dmochowski R: Urinary Bladder Histologic Changes

Associated with Chronic Indwelling Urinary Catheters. Poster Presentation. American Urologic Association Annual Meeting. New Orleans, Louisiana, April, 1997.

74. Kochakarn W, Gojseni P, Muangman V, Viseshindh V, Ratana-Olarn K, Leungwattanakij

S, Dmochowski R: Operative Repair of 222 Cases of Vesico-Vaginal Fistulas. Poster Presentation. American Urologic Association Annual Meeting. New Orleans, Louisiana, April, 1997.

75. Kochakarn W, Muangaman V, Krauwit A, Saksri B, Chaivananichsiri P, Dmochowski R:

Traumatic Penile Amputation: Results with Primary Attachment. Poster Presentation. American Urologic Association Annual Meeting. New Orleans, Louisiana April, 1997

76. Kochakarn W, Go]seni P, Muangman V, Viseshindh V, Hatana-Olarn K, Leungwattanakij

S, Dmochowski R: Operative Repair of 222 Cases of Vesico-Vaginal Fistulas. Foster Presentation. Urodynamic Society Annual Meeting. New Orleans, Louisiana, April, 1997

77. Gubin DA, Dmochowski RH, Kutteh WA: Multivariant Analysis of Men with Antisperm

Antibodies From Infertile Couples. Poster Presentation. American Society of Reproductive Immunology. Vancouver, B.C. June, 1997.

78. Abel TL, Chiang C, Hashed H, Faimloni J, Goldman H, Dmochowski. R.: EGG Predicts

Bladder Abnormalities in Patients with Symptoms Of Gastroparesis. Fifth Internatoinal Workshop on Electrogastrography. Washington, DC, May 1997.

79. Rashed H, Goldman H, Dmochowski R, Abel TL: Lower Urinary Tract Dysfunction and

Gastropares's Have a Common Autonomic Mechanism. Annual Meeting American Diabe:ic Association . May, 1997.

80. Goldman H, Dmochowski R, AbelI TL: Lower Urinary Tract Dysfunction is Common in

Patiets with Symptoms of Gastroparesis. American Gastroenterological Association. May, 1 1997.

81. Kochakarn W, Gojseni P, Muangman V, Ratana-Olarn K, Dmochowski R: Outcome of

Urethral Stricture Management. International Genitourinary Reconstructive Surgeons Society meeting. London, England. May, 1997.

26

82. Dmochowski R., Idom CB, Goldman HB; Penetrating Urethral Trauma. International Genitourinary Reconstructive Surgeons Society meeting. London, England. May, 1997.

83. Kochakarn W, Gojseni P, Muangman V, Viseshindh V, Ratana-Olarn K, Leungwattanakij

S, Dmochowski R: Operative Repair of 222 Cases of Vesico-Vaginal Fistulas. Podium Presentation. Society of International Urology. Montreal, Canada, Sept., 1997.

84. Leach G., Dmochowski R., Appell R., Blaivas J.G., Hadley R., Luber K., Mostwin

J.,O'Donnell P.: Female Stress Urinary Incontinence Clinical Guidelines Panel Summary Report on Surgical Treatment of Female Stress Urinary Incontinence. National Women's Convention. Washington, D.C. June, 1997.

85. Hollabaugh R. Steiner MS, Dmochowski RR: Neuroanatomy of the Female Continence

Nerves. Podium Presentation. Society of International Urology. Montreal, Canada. Sept., 1997.

86. Rashed H, Dmochowski R, Goldman H, Cardoso S, Thompson L, Abell TL: Autonomic

Function Test Predicts Urinary Bladder Abnormalities in Patients with Symptoms of Gastroparesis. Podium Presentation. American Autonomic Society. San Francisco, Ca. Nov., 1997.

87. Gubin DA, Dmochowski RR, Kutteh WA: Mulitvariant Analysis of Men with Antisperm

Antibodies From Infertile Couples. Poster Presentation. Southeastern Section American Urologic Association. Birmingham , Al. April, 1998.

88. Hollabaugh RS, Dmochowski RR, Kneib T, Steiner MS: Neuroanatomical Considerations

for Urologic Injury following Abdominoperineal Resection. Poster Presentation. Southeastern Section American Urologic Association. Birmingham , Al. April, 1998.

89. Hollabaugh RS, Dmochowski RR, Kneib T, Steiner MS: Preservation of Putative

Continence Nerves During Radical Retropubic Prostatectomy Leads to More Rapid Return of Urinary Continence. Podium Presentation. Southeastern Section American Urologic Association. Birmingham , Al. April, 1998.

90. Idom HB, McGrath J, Fabian T, Dmochowski RR: Combined rectal and urologic traumatic

injuries. Podium Presentation. Southeastern Section American Urologic Association. Birmingham , Al. April, 1998.

91. Samm BJ, Rueff SA, Dmochowski RR: Penetrating injuries of the upper urinary tract.

Podium Presentation. Southeastern Section American Urologic Association. Birmingham , Al. April, 1998.

92. Idom HB, McGrath J, Fabian T, Dmochowski RR: Combined rectal and urologic traumatic

injuries. Podium Presentation . American Urologic Association Annual Meeting, San Diego, Ca. May, 1998.

93. Samm BJ, Rueff SA, Dmochowski RR: Penetrating injuries of the upper urinary tract.

Podium Presentation. American Urologic Association Annual Meeting, San Diego, Ca. May, 1998.

27

94. Idom HB, Goldman HB, Dmochowski RR: Penetrating urethral injuries. Poster

Presentation. American Urologic Association Annual Meeting, San Diego, Ca. May, 1998.

95. Wall B, Weld K, Dmochowski RR: Nitric Oxide production in the neurogenic bladder.

So. Section Gen Internal Medicine. New Orleans, La. Feb, 1999. 96. Weld K, Dmochowski RR: Association of completeness of spinal cord injury and

detrusor sphincter dyssynergia. Southeastern Section A.U.A. Charleston , S.C., April, 1999.

96. Weld K, Dmochowski RR: Changes in bladder compliance over time and effects of

bladder management on compliance in spinal cord injury patients. Southeastern Section A.U.A. Charleston , S.C., April, 1999.

97. Kobashi KC, Dmochowski R, Mee SL, Mostwin J, Nitti V, Zimmern PE, Leach GE:

Erosion of woven polyester synthetic (Protogen) pubovaginal sling. Urodynamic Society, Dallas, Tx., May, 1999.


bladder management on compliance in spinal cord injury patients. Urodynamic Society. Dallas, Tx., April, 1999.

99. Kobashi KC, Dmochowski R, Mee SL, Mostwin J, Nitti V, Zimmern PE, Leach GE:

Erosion of woven polyester synthetic (Protogen) pubovaginal sling. Urodynamic Society, Dallas, Tx., May, 1999.


bladder management on compliance in spinal cord injury patients. A.U.A. Annual meeting. Dallas, Tx., May, 1999.


bladder management on compliance in spinal cord injury patients. International Continence Society, Denver Co., Sept., 1999.

102. Weld K, Dmochowski RR: Association of completeness of spinal cord injury and

detrusor sphincter dyssynergia. International Continence Society, Denver Co., Sept., 1999.

103. Weld K, Dmochowski RR: Complications associated with type of bladder management

method in spinal cord injury patients. International Continence Society, Denver Co., Sept., 1999.

104. Weld K, Dmochowski RR: Complications associated with type of bladder management

method in spinal cord injury patients. Southeastern Section A.U.A., Orlando Fl., Mar, 2000.

28

105. Weld K, Dmochowski RR: Influences on Renal function in Spinal Cord Injury Patients. Southeastern. Section A.U.A., Orlando Fl., Mar, 2000.

106. Weld K, Dmochowski RR: Association of completeness of spinal cord injury and

detrusor sphincter dyssynergia. A.U.A. Annual Meeting., Atlanta, Ga., Apr.,2000.

107. Weld K, Dmochowski RR: Complications associated with type of bladder management method in spinal cord injury patients. A.U.A. Annual Meeting., Atlanta, Ga., Apr.,2000.

108. Nitti V, Carlson K, Dmochowski RR, Blaivas J: A simplified method of pubovaginal

sling lysis: description and early results. Urodynamics Society Annual Meeting., Atlanta, Ga., Apr.,2000.

109. Weld K, Dmochowski RR: Influences on Renal function in Spinal Cord Injury Patients.

Urodynamics Society Annual Meeting., Atlanta, Ga., Apr.,2000.

110. Nitti V, Carlson K, Dmochowski RR, Blaivas J: A simplified method of pubovaginal sling lysis: description and early results. Urodynamics Society Annual Meeting., Atlanta, Ga., Apr.,2000.

111. Dmochowski R, Galen D. Evaluation of subacute tissue response in an animal model to

evaluate a novel therapy to treat stress urinary incontinence. International Continence Society, Tampere, Finland, Aug. 2000.

112. Dmochowski R, A Minimally invasive technique to shrink the endopelvic fascia for the

treatment of SUI: Initial safety and efficacy profile of two surgical approaches. International Continence Society, Tampere, Finland, Aug. 2000.

113. Weld K, Dmochowski RR: Clinical significance of detrusor sphincter dyssynergia type

in post traumatic spinal cord injury patients. International Continence Society, Tampere, Finland, Aug. 2000.

114. Weld K, Dmochowski RR: Association of radiographically determined level of injury

and bladder behavior in post traumatic spinal cord injury patients. International Continence Society, Tampere, Finland, Aug. 2000.

115. Weld K, Dmochowski RR: Influences on Renal function in Spinal Cord Injury Patients.

International Continence Society, Tampere, Finland, Aug. 2000.

116. Koduri S, Dmochowski R, Sand P. The Transvaginal Cooper’s Ligament Sling: A New Minimally Invasive Surgery. International Continence Society, Tampere, Finland, Aug. 2000.

117. Koduri S, Dmochowski R, Sand P. The Cooper’s Ligament Transvaginal

Sling.International Urogynecologic Society, Rome, Italy, Oct. 2000.

29

118. Koduri S, Dmochowski R, Sand P. Minimally Invasive Surgery: The Cooper’s Ligament Transvaginal Sling. American Urogynecologic Society. Hilton Head, S.C., Oct 2000.

119. Dmochowski RR, Albala D, Avon M. Transvaginal radiofrequency bladder neck

suspension: a novel minimally invasive approach to the treatment of stress urinary incontinence. AUA annual meeting, Anaheim CA, June 2001.

120. Weld KJ, Dmochowski RR. Effects of post traumatic syringomyelia on bladder

function. AUA annual meeting, Anaheim CA, June 2001.

121. Lemack G, Dmochowski RR, Wilson T, Margulis V. Difficulties associated with use of the urolume prosthesis: lessons learned. AUA annual meeting, Anaheim CA, June 2001.

122. Barnes N, Park R, Dmochowski RR, Nitti V. Morbidity of simultaneous pubovaginal

sling and prolapse repair in women with occult stress urinary incontinence. Urodynamics Society annual meeting, Anaheim CA, June 2001.

123. Graham C, Dmochowski RR. Pubic osteomyelitis following bladder neck suspension

using bone anchors: a report of nine cases. Urodynamics Society annual meeting, Anaheim CA, June 2001.

124. Davila GW, Sanders SW, Lyttle S, Gittelman M, Zinner N, Saltzstein DR,

Dmochowski R. Transdermal ocybutynin is safe, effective, and improves quality of life in patients with overactive bladder. Urodynamics Society annual meeting, Anaheim CA, June 2001

125. Dmochowski RR, Galen D. Evaluation of subacute tissue response in an animal model

to evaluate a novel therapy to treat stress urinary incontinence. Urodynamics Society annual meeting, Anaheim CA, June 2001.

126. Fowler B, Kirkman T, Dmochowski RR, StaskinDR. Comparative study of healing

responses to various materials subjected to periodic stresses in the rabbit pelvis. Urodynamics Society annual meeting, Anaheim CA, June 2001.

127. Dmochowski R, Avon M, Ross J, Kaplan R, Love B. Safety and efficacy of the

transvaginal radiofrequency bladder neck suspension procedure. 2nd International Consultation on Incontinence, Paris, Fr. July 1- 3, 2001.

128. Dmochowski R, Galen D. Comparison of safety and efficacy of the transvaginal

radiofrequency bladder neck suspension to traditional surgical approaches for the treatment of genuine stress incontinence. . 2nd International Consultation on Incontinence, Paris, Fr. July 1- 3, 2001.

129. Dmochowski R, Avon M, Ross J, Cooper J, Kaplan R, Love B. Key factors in

improving the results of the transvaginal radiofrequency bladder neck suspension. 2nd International Consultation on Incontinence, Paris, Fr. July 1- 3, 2001.

30

130. Dmochowski R, Kell SH. FDA spontaneous reports of central nervous system (CNS) adverse events with Ditropan XL and Detrol for overactive bladder. 2nd International Consultation on Incontinence, Paris, Fr. July 1- 3, 2001.

131. Dmochowski R, Sathyan G, Ye C, Gupta SK. The effect of ph on drug release from

extended release formulations of oxybutynin and tolterodine. 2nd International Consultation on Incontinence, Paris, Fr. July 1- 3, 2001.

132. Staskin DR, Appell RA, Dmochowski R, Albrecht D. Central nervous system adverse

events with anticholinergic medication for overactive bladder. 2nd International Consultation on Incontinence, Paris, Fr. July 1- 3, 2001.

133. Appell RA, Dmochowski R, Staskin D, Albrecht D. Randomized double blind study of

extended release oxybutynin and tolterodine for overactive bladder in female patients. 2nd International Consultation on Incontinence, Paris, Fr. July 1- 3, 2001.

134. Deviere, J., Wustenberg, W., Mishra, N., Kammula, R., Hook, G., Dmochowski, R.,

Silverman, D., Berryman, T.A Transgenic Mouse Model for Carcinogenicity Testing of Enteryx™ - An Implantable Biopolymer for Treatment of GERD. European Gastroeneterology Assoc. Louvain, Belgium, Sept 2001.

135. R.Dmochowski, M.Avon, J. Ross, J. Cooper, R. Kaplan, B. Love, R. Cowles, R. Kohli, D.

Albala, B. Shingleton. Comparison of the Safety and Efficacy of the Transvaginal Radio Frequency Bladder Neck Suspension Procedure to Traditional Surgical Approaches for Stress Urinary Incontinence. International Continence Society, Seoul, South Korea, Sept 2001.

136. Graham C, Dmochowski RR. Pubic osteomyelitis following bladder neck suspension using

bone anchors: a report of nine cases. International Continence Society, Seoul, South Korea, Sept 2001.

137. Young M, Dmochowski R , Galt K. Soft Tissue Reaction and Healing Characteristics

Associated with URyX, A New Bulking Agent Proposed for the Lower Urinary Tract. International Continence Society, Seoul, South Korea, Sept 2001.

138. Deviere, J., Wustenberg, W., Mishra, N., Kammula, R., Hook, G., Dmochowski, R.,

Silverman, D., Berryman, T.A Transgenic Mouse Model for Carcinogenicity Testing of Uryx™ - An Implantable Biopolymer for Treatment of Urinary Incontinence. International Continence Society, Seoul, South Korea, Sept 2001.

139. Davila GW, Sanders SW, Lyttle S, Gittelman M, Zinner N, Saltzstein DR, Dmochowski R.

Transdermal ocybutynin is safe, effective, and improves quality of life in patients with overactive bladder. International Continence Society, Seoul, South Korea, Sept 2001.

140. Dmochowski, R , Avon M, Ross J , Cooper J., Kaplan R. , Love B. , Cowles R,. Kohli, N.,

Albala, D. Shingleton B. Safety and Efficacy of the Transvaginal Radio Frequency Bladder Neck Suspension Procedure. International Continence Society, Seoul, South Korea, Sept 2001

31

141. Dmochowski, R , Avon M, Ross J , Cooper J., Kaplan R. , Love B. , Cowles R,. Kohli, N., Albala, D. Shingleton B. Key Factors in Improving the Results of the Transvaginal Radio Frequency Bladder Neck Suspension. International Continence Society, Seoul, South Korea, Sept 2001.

142. Silver F. , DeVore D., Dmochowski R. Biomechanical Properties of Dermis and Fascia:

Differences in Specific Testing Modalities. International Continence Society, Seoul, South Korea, Sept 2001.

143. Silver F, DeVore DP, Dmochowski R. Correlation of Suture Pull Strength to Dermal

Allograft Strip Thickness: How Thick Should Grafts Be?. International Continence Society, Seoul, South Korea, Sept 2001.

144. Fowler B, Kirkman T, Dmochowski RR, StaskinDR. Comparative study of healing

responses to various materials subjected to periodic stresses in the rabbit pelvis. International Continence Society, Seoul, South Korea, Sept 2001.

145. Graham CG, Dmochowski RR: Questionnaires for women with lower urinary tract

symptoms. International Continence Society, Seoul, South Korea, Sept 2001.

146. Staskin DR, Appell R, Dmochowski R, Albrecht D. Central Nervous System adverse events with anticholinergic medication for overactive bladder. International Continence Society, Seoul, South Korea, Sept 2001.

147. Dmochowski R, Kell SH. FDA spontaneous reports of central nervous system (cns)

adverse events with Ditropan XL and Detrol for overactive bladder. International Continence Society, Seoul, South Korea, Sept 2001.

148. Appell R, Dmochowski R, Staskin D, Albrecht D. Randomized, double blind study of

extended release oxybutynin and tolterodine for overactive bladder in female patients. International Continence Society, Seoul, South Korea, Sept 2001.

149. Dmochowski RR, Sathyan G, Ye C, Gupta SK. The effect of ph on drug release from

extended release formulations of oxybutynin and tolterodine. International Continence Society, Seoul, South Korea, Sept 2001.

150. Dmochowski R, ,Appell R, Sand P et al. Randomized double blind study of controlled

release oxybutynin and tolterodine for overactive bladder in female patients. New England Section AUA, Newport , R.I., Oct 11 – 15, 2001.

151. Dmochowski R, Appell R, Sand P et al. Central nervous system adverse events with

anticholinergic medication for overactive bladder. New England Section AUA, Newport , R.I., Oct 11 – 15, 2001.

152. Dmochowski, R , Avon M, Ross J , Cooper J., Kaplan R. , Love B. , Cowles R,. Kohli, N.,

Albala, D. Shingleton B. Safety and Efficacy of the Transvaginal Radio Frequency Bladder Neck Suspension Procedure. American Urogynecologic Society, Chicago, Il, Oct 2001.

32

153. Dmochowski, R , Avon M, Ross J , Cooper J., Kaplan R. , Love B. , Cowles R,. Kohli, N., Albala, D. Shingleton B. Key Factors in Improving the Results of the Transvaginal Radio Frequency Bladder Neck Suspension. American Urogynecologic Society, Chicago, Il, Oct 2001.

154. Sand P,Appell R, Dmochowski R et al. Randomized double blind study of controlled

release oxybutynin and tolterodine for overactive bladder in female patients. American Urogynecologic Society, Chicago, Il, Oct 2001.

155. Sand P, Anderson R, Dmochowski et al. Central nervous system adverse events with

anticholinergic medication for overactive bladder. American Urogynecologic Society, Chicago, Il, Oct 2001.

156. Davila GW, Sanders SW, Lyttle S, Gittelman M, Zinner N, Saltzstein DR, Dmochowski R.

Transdermal ocybutynin is safe, effective, and improves quality of life in patients with overactive bladder. American Urogynecologic Society, Chicago, Il, Oct 2001.

157. Koduri S, Goldberg R , Sand P, Dmochowski R. The Transvaginal Cooper’s Ligament

Sling : One Year Follow up. American Urogynecologic Society, Chicago, Il, Oct 2001.

158. Dmochowski, R , Avon M, Ross J , Cooper J., Kaplan R. , Love B. , Cowles R,. Kohli, N., Albala, D. Shingleton B. Key Factors in Improving the Results of the Transvaginal Radio Frequency Bladder Neck Suspension. European Urologic Society, Birmingham UK, Feb. 2002.

159. Dmochowski, R , Avon M, Ross J , Cooper J., Kaplan R. , Love B. , Cowles R,. Kohli,

N., Albala, D. Shingleton B. Safety and Efficacy of the Transvaginal Radio Frequency Bladder Neck Suspension Procedure. European Urologic Society, Birmingham UK, Feb. 2002.

160. Davila GW, Dmochowski RR, Sanders SW. Influence of age on improvement in OAB

symptoms and adverse events during Oxybutynin TDS treatment. American College of Obstetrics and Gynecology, Chicago, Ill. June 2002.

161. Davila GW, Dmochowski RR, Sanders SW. Anticholinergic side effects with long-term

transdermal oxybutynin for overactive bladder symptoms. American College of Obstetrics and Gynecology, Chicago, Ill. June 2002.

162. Davila GW, Dmochowski RR, Sanders SW. Does hormone replacement affect OAB

symptoms and quality of life during Oxybutynin TDS therapy. American College of Obstetrics and Gynecology, Chicago, Ill. June 2002.

163. Dmochowski RR, Davila GW, Sanders SW. Anticholinergic and other adverse events

with transdermal oxybutynin for overactive bladder in patients > 70 years. American Geriatrics Society, Washington, DC. May 2002.

164. Dmochowski RR, Sathyan G, Ye C, Gupta K. In vivo study of the effect of antacid on

extended release formulations of oxybutynin and tolterodine. American Geriatrics Society, Washington, DC. May 2002.

33

165. Dmochowski RR, Kell SH. The safety profile of two drugs for overactive bladder: A

comparison of prescribing information for each drug and head – to - head study. American Geriatrics Society, Washington, DC. May 2002.

166. Dmochowski RR, Kell SH. Community based study of quality of life in patients treated

for overactive bladder. American Geriatrics Society, Washington, DC. May 2002.

167. Scarpero H, Dmochowski RR, Nitti V. Repeat urethrolysis following failed urethrolysis for iatrogenic obstruction. Society for female urology and urodynamics annual meeting. Orlando, FL, May 2002.

168. Dmochowski, R , Avon M, Ross J , Cooper J., Kaplan R. , Love B. , Cowles R,. Kohli,

N., Albala, D. Shingleton B. Safety and Efficacy of the Transvaginal Radio Frequency Bladder Neck Suspension Procedure. American Urologic Association annual meeting. Orlando, FL, May 2002.

169. Scarpero H, Dmochowski RR, Nitti V. Repeat urethrolysis following failed urethrolysis

for iatrogenic obstruction. American Urologic Association annual meeting. Orlando, FL, May 2002.

170. Rudy DC, Dmochowski RR. Lower motor neuron bladder after radical retropubic

prostatectomy. American Urologic Association annual meeting. Orlando, FL, May 2002.

171. Dmochowski RR, Norton P,. Zinner N, Miklos J, Yalcin I, Bump R. Duloxitene vs

Placebo in the treatment of stress urinary incontinence. American Urologic Association annual meeting. Orlando, FL, May 2002.

172. Dmochowski RR, Herschorn S, Corcos J, Karram M, Pommerville P, Berger Y,

Radomski S, Jacoby K, Foote J, Cornell J, Bent A, Chaikin D. Multicenter Randomized Controlled Study to evaluate Uryx urethral bulking agent in treating female stress urinary incontinence. American Urologic Association annual meeting. Orlando, FL, May 2002.

173. Davila W, Sanders S, Dmochowski R. Reduced nocturia and daytime urinary frequency

in response to oxybutynin transdermal delivery (OXY TDS). International Urogynecologic Society. Prague, CZ, Aug 2002.

174. Norton PA, Dmochowski RR, Miklos JR, Zinner NR, Yalcin I, Bump RC.

Comparisons of female incontinence (SUI) with and without overactive bladder (OAB) symptoms. International Urogynecologic Society. Prague, CZ, Aug 2002.

175. Davila W, Sanders S, Dmochowski R. Transdermal oxybutynin (OXY TDS) for

overactive bladder reduces anticholinergic side effects. International Urogynecologic Society. Prague, CZ, Aug 2002.

34

176. Sand P, Dmochowski R, Appell RA, Klimberg I, Mayer R. Initial clinical results from Coaptite injection for stress urinary incontinence, comparative clinical study. International Urogynecologic Society. Prague, CZ, Aug 2002.

177. Karram M, Dmochowski RR, Herschorn S, Corcos J, Karram M, Pommerville P,

Berger Y, Radomski S, Jacoby K, Foote J, Cornell J, Bent A, Chaikin D. Multicenter Randomized Controlled Study to evaluate Uryx urethral bulking agent in treating female stress urinary incontinence. International Urogynecologic Society. Prague, CZ, Aug 2002.

178. Appell RA, Dmochowski RR. Treatment of non urge (stress) incontinence and

nighttime voiding (nocturia) in patients with urge predominant incontinence. International Continence Society, Heidelberg, Ger, Aug 2002.

179. Appell RA, Dmochowski RR. Long term safety update: extended release oxybutynin.

International Continence Society, Heidelberg, Ger, Aug 2002

180. Dmochowski R, Herschorn S, Corcos J, Karram M, Pommerville P, Berger Y, Radomski S, Jacoby K, Foote J, Cornella J, Bent A. Multicenter randomized controlled study to evaluate URYX urethral bulking agent in treating female stress urinary incontinence. International Continence Society, Heidelberg, Ger, Aug 2002.

181. Dmochowski R, Davila W, Sanders S. Transdermal oxybutynin and controlled release

oral tolterodine in patients with positive treatment effect to anticholinergic therapy for overactive bladder. International Continence Society, Heidelberg, Ger, Aug 2002.

182. Dmochowski R, Appell RA, Klimberg I, Mayer R. Initial clinical results from Coaptite

injection for stress urinary incontinence, comparative clinical study. International Continence Society, Heidelberg, Ger, Aug 2002.

183. Zinner N, Dmochowski RR, Norton P, Miklos J, Yalcin I, Bump R. Duloxitene vs

Placebo in the treatment of stress urinary incontinence. International Continence Society, Heidelberg, Ger, Aug 2002.

184. Karram M, Dmochowski RR, Herschorn S, Corcos J, Karram M, Pommerville P,

Berger Y, Radomski S, Jacoby K, Foote J, Cornell J, Bent A, Chaikin D. Multicenter Randomized Controlled Study to evaluate Uryx urethral bulking agent in treating female stress urinary incontinence. American Urogynecologic Society. San Francisco, CA, Oct. 2002.

185. Dmochowski RR, Davila GW, Sanders SW. Transdermal oxybutynin and Controlled

release oral tolterodine in patients with positive treatment effect to anticholinergic therapy for overactive bladder. American Urogynecologic Society. San Francisco, CA, Oct. 2002.

186. Davila GW, Dmochowski RR, Zobrist RH, Thomas HA. Salivary output and

Pharmacokinetics during transdermal and extended release oral oxybutynin administration. American Urogynecologic Society. San Francisco, CA, Oct. 2002.

35

187. Davila GW, Dmochowski RR, Sanders SW. Transdermal and oral oxybutynin: comparison of anticholinergic side effects. American Urogynecologic Society. San Francisco, CA, Oct. 2002.

188. Norton PA, Dmochowski RR, Miklos JR, Zinner NR, Yalcin I, Bump RC. Mixed stress

urinary incontinence (SUI) and overactive bladder (OAB) symptoms: Observation on symptom severity and response to Duloxitene. American Urogynecologic Society. San Francisco, CA, Oct. 2002.

189. Dmochowski R, Herschorn S, Corcos J, Karram M, Pommerville P, Berger Y,

Radomski S, Jacoby K, Foote J, Cornella J, Bent A. Multicenter randomized controlled study to evaluate URYX urethral bulking agent in treating female stress urinary incontinence. Society of Female Urology and Urodynamics, Chicago, Il, April, 03.

190. Dmochowski R, Staskin D. 3 Day urinary diaries improve assessment of overactive

bladder symptoms compared to 7 day diaries, Society of Female Urology and Urodynamics, Chicago, Il, April, 03.


Radomski S, Jacoby K, Foote J, Cornella J, Bent A. Multicenter randomized controlled study to evaluate URYX urethral bulking agent in treating female stress urinary incontinence. AUA annual meeting, Chicago, Il, April, 03.

192. Gomelsky A, Rudy D, Dmochowski RR. Voiding dysfunction in patients with high-

grade pelvic organ prolapse. AUA Annual Meeting, Chicago, Il, April, 03.

193. Gomelsky A, Rudy D, Dmochowski RR. Repair of high – grade anterior compartment defects with porcine dermis interposition graft. AUA Annual Meeting, Chicago, Il, April, 03.

194. Gomelsky A, Rudy D, Dmochowski RR. Results of iliococcygeus vault suspension for

vaginal prolapse. AUA Annual Meeting, Chicago, Il, April, 03. 195. Dmochowski RR, Zinner NR, Davila GW. Oxytrol Transdermal delivery for the

treatment of overactive bladder in the 70 year old patient: safety with up to 52 weeks of treatment. American Geriatric Society, Baltimore, MD, May 03.

195. Luber K, Dmochowski RR. Effect of advanced age on the pharmacokinetics and

adverse events related to transdermal therapy. American Geriatric Society, Baltimore, MD, May 03.


Radomski S, Jacoby K, Foote J, Cornella J, Bent A. Multicenter randomized controlled study to evaluate URYX urethral bulking agent in treating female stress urinary incontinence. International Continence Society, Florence, Italy. Oct 03.

197. Dmochowski RR, Staskin DR, Appell R, Zinner N, Gittelman M, Davila G, Sand P.

The efficacy, effectiveness, and safety of transdermal oxybutynin in patients with overactive bladder. International Continence Society, Florence, Italy. Oct 03.

36

198. Dmochowski RR, Heit M, Sand P. The effect of anticholinergic therapy on urgency

severity in patients with overactive bladder: clinical assessment of a newly validated tool. International Continence Society, Florence, Italy. Oct 03.

199. Sand P, Dmochowski RR. Trospium chloride improves symptoms of overactive bladder

within one week. International Continence Society, Florence, Italy. Oct 03.

200. Appell RA, Dmochowski R, Klimberg I, Mayer R. Clinical results from Coaptite injection for stress urinary incontinence, comparative clinical study. International Continence Society, Florence, Italy. Oct 03.

201. Dmochowski RR, Heit M, Sand P. The effect of anticholinergic therapy on urgency

severity in patients with overactive bladder: clinical assessment of a newly validated tool. International Urogynecologic Society, Buenos Aires, Argentina, Oct 03.


Radomski S, Jacoby K, Foote J, Cornella J, Bent A. Multicenter randomized controlled study to evaluate URYX urethral bulking agent in treating female stress urinary incontinence. Society of Female urology and Urodynamics, Phoenix, AZ Feb 2004.


Radomski S, Jacoby K, Foote J, Cornella J, Bent A. Multicenter randomized controlled study to evaluate URYX urethral bulking agent in treating female stress urinary incontinence. American Urologic Association, San Francisco, CA May 2004.

204. Cole EE, Leu PB, Revelo P, Shappell H, Scarpero HM, Dmochowski RR.

Histopathologic evaluation of the uterosacral ligament. American Urologic Association, San Francisco, CA May 2004.

205. Dmochowski R, Levy B, Lucente V, Ross J. Transvaginal Radio Frequency Bladder

Neck Suspension: Long term follow up. Society of Female Urology and Urodynamics, Phoenix AZ, Feb 27 – 29, 2004.

206. Dmochowski RR, Herschorn S, Corcos J, Karram M, Pommerville P, Berger Y, Radomski S, Jacoby K, Foote J, Cornella J, Bent A. Multicenter randomized controlled study to evaluate URYX urethral bulking agent in treating female stress urinary incontinence. Society of Female Urology and Urodynamics, Phoenix AZ, Feb 27 – 29, 2004.

207. Newman D, Dmochowski R. Population analysis of OAB trends: Summary of Harris survey for voiding dysfunction. Society of Female Urology and Urodynamics, Phoenix AZ, Feb 27 – 29, 2004.

208. Newman D, Dmochowski R. Impact of overactive bladder in women: effects in the workplace. ACOG 52nd Annual Meeting, Philadelphia PA, May 5, 2004.

209. Dmochowski RR, Herschorn S, Corcos J, Karram M, Pommerville P, Berger Y, Radomski S, Jacoby K, Foote J, Cornella J, Bent A. Multicenter randomized controlled study to evaluate URYX urethral bulking agent in treating female stress urinary incontinence. AUA Annual meeting, San Francisco Ca, May, 2004.

37

210. Cole E, Scarpero H, Dmochowski RR. The uterosacral ligament: A Reasonable structure for pelvic reconstruction. AUA Annual meeting, San Francisco Ca, May, 2004.

211. Dmochowski R, Leu P, Wu H, Scarpero H. High grade pelvic organ prolapse and clinical and urodynamic findings. ICS and IUGA 2004 Abstract CD-ROM and ICS Website.

212. Dmochowski R, Herschorn S, Karram M, Corcos J, Pommerville P, Bent A, Berger Y, Cornella J, Foote J, Jacoby K, Radomski S, Kennelly M. Multicenter Randomized Controlled Trial to Evaluate URYX Urethral Bulking Agent in Treating Female Stress Urinary Incontinence: Comparison of Initial and Expansion Phases of Trial. ICS and IUGA 2004 Abstract CD-ROM and ICS Webside.

213. Dmochowski R, Leu P, Wu H, Scarpero H. Effect of prior pelvic surgery on clinical and urodynamic parameters in women with high grade pelvic organ prolapse. ICS & IUGA 2004 Absttract CD-ROM and ICS Website.

214. Dmochowski R, Ross J, Levy B, Lucente V. Durability of Therapeutic Effects of a Radio Frequency Energy Procedure for Mild-to-Moderate Genuine Stress Incontinence at Three-Year Follow-up. ISC and IUGA 2004 Abstract CD-ROM and ICS Website.

215. Cole E, Woodruff A, Scarpero H, Dmochowski R., Winters JC. Histological comparison of pubovaginal sling graft materials: A comparison. Society of Female Urology and Urodynamics. Orlando,FL. Feb, 2005.

216. Cole E, Scarpero H, Dmochowski R. Are patient symptoms predictive of the diagnostic and / or therapeutic value of hydrodistention? Society of Female Urology and Urodynamics. Orlando,FL. Feb, 2005Orlando,FL. Feb, 2005. Society of Female Urology and Urodynamics. Orlando, FL. Feb, 2005.

217. Cole E, Scarpero H, Dmochowski R. The effects of isolated posterior compartment defects on lower urinary tract symptoms and urodynamic findings. Society of Female Urology and Urodynamics. Orlando, FL. Feb, 2005.

218. Cole E, Scarpero H, Dmochowski R The correlation of symptoms with urodynamic findings in patients with high grade pelvic organ prolapse. Society of Female Urology and Urodynamics. Orlando, FL. Feb, 2005.

219. Cole E, Woodruff A, Scarpero H, Dmochowski R., Winters JC. Histological comparison of pubovaginal sling graft materials: A comparison. AUA annual meeting, San Antonio, Tx, May 2005.

220. Cole E, Scarpero H, Dmochowski R. Urodynamic findings associated with high grade pelvic organ prolapse. AUA annual meeting, San Antonio, Tx, May 2005.

221. Dmochowski R. Depression in Older Adults with Overactive Bladder. Geriatric Urologic Society, San Antonio, Tx, May 2005.

222. Staskin DR, Tyagi R, Dmochowski R. Effect of a fixed dose of extended-release oxybutynin on urge and non-urge urinary incontinence. International Continence Society, Montreal, Cn, Aug 2005.

223. Dmochowski R, Guan E, Carlsson M, Nitti V. Clinical efficacy of tolterodine extended release is maintained for 24 hours in patients with overactive bladder. International Continence Society, Montreal, Cn, Aug 2005.

224. Zinner N, Harnett M, Sandage B, Sabounjian L, Dmochowski R, StaskinD. Utility of the OAB composite score. International Continence Society, Montreal, Cn, Aug 2005.

225. Dmochowski R, MacDiarmid S. Individualized dosing of extended-release oxybutynin is associated improved outcomes in the treatment of urge incontinence. International Continence Society, Montreal, Cn, Aug 2005.

38

226. Dmochowski R, Lucent V, MacDiarmid S, Parker R, Davila W, McIlwain M. International Continence Society, Montreal, Cn, Aug 2005.

227. Starkman J, Gomelski A, Scarpero H, Dmochowski R. Voiding dysfunction following explantation of mid-urethral synthetic slings due to tap erosion. Society of Urodynamics and Female Urology. Freeport, Bahamas. Feb 23 – 25, 2006.

228. Starkman J, Scarpero H, Milam D, Dmochowski R. Sacral Neuromodulation following urogynecologic procedures for refractory storage symptoms. Society of Urodynamics and Female Urology. Freeport, Bahamas. Feb 23 – 25, 2006.

229. Shenot P, Dmochowski R, MacDiarmid S, Zinner N, McIlwain M. Comparing the impact of transdermal oxybutynin on nocturia and related symptoms in men and women with overactive bladder: Results from the Matrix trial. Society of Urodynamics and Female Urology. Freeport, Bahamas. Feb 23 – 25, 2006.

230. Mayer R, Dmochowski R, Appell R. A 52 week trial of calcium hydroxylapatite vs. bovine collagen for treatment of stress urinary incontinence. Society of Urodynamics and Female Urology. Freeport, Bahamas. Feb 23 – 25, 2006.

231. Hamad RA, Dmochowski RR, McIlwain M, et al. Matrix results: Does quality of life differ in overactive bladder patients older and younger than 75 years treated with transdermal. oxybutynin? J Am Geriatr Soc 2006 Apr 1; 54 (Suppl. No. 4):22.

232. Starkman JS, Scarpero H, Milam D, Dmochowski RR. Management of Refractory Urinary Urge Incontinence Following Urogynecologic Surgery with Sacral Neuromodulation. AUA annual meeting, Atlanta, GA, May 2006.

233. Nitti V, Dmochowski R, Williams T, Alvarez-Jacinto, O. Efficacy, Safety, and Tolerability of Fesoterodine in Patients With Overactive Bladder: a Phase 3 Placebo controlled Trial in the United States. AUA annual meeting, Atlanta, GA, May 2006.

234. Mayer R, Dmochowski R, Appell R. A 52 week trial of calcium hydroxylapatite vs. bovine collagen for treatment of stress urinary incontinence. AUA annual meeting, Atlanta, GA, May 2006.

235. Starkman JS, Gomelsky, A. Scarpero H, Dmochowski RR Voiding dysfunction following explantation of synthetic mid-urethral slings due to tape erosion. AUA annual meeting, Atlanta, GA, May 2006.

236. Starkman JS, Scarpero H, Milam D, Dmochowski RR. Sacral neuromodulation: results from a large single institutional experience. AUA annual meeting, Atlanta, GA, May 2006.

237. Staskin DR, Nitti V, Dmochowski R. Quality of life following treatment with transdermal oxybutynin: the effects of prior therapy. ICS annual meeting, Christchurch NZ, Dec, 2006.

238. Dmochowski R, Staskin D. Once daily trospium chloride; results of randomized trial. ICS annual meeting, Christchurch NZ, Dec, 2006.

239. Starkman J, Duffy J, Wolter C, Kaufman M, Scarpero H, Dmochowski R. The evolution of obstruction induced overactive bladder (OAB) symptoms following urethrolysis for female bladder outlet obstruction. Society of Female Urology and Urodynamics, San Diego, CA, Feb 21 -24, 2007.

240. Coons B, Harris C, Starkman J, Scarpero H, Dmochowski R, Milam D. Sacral neuromodulation (Interstim) and its effects on non-obstructive urinary retention in men. Society of Female Urology and Urodynamics, San Diego, CA, Feb 21 -24, 2007.

241. Dmochowski R, Zinner N, Sand P. Trospium chloride extended release formulation provides effective relief for the symptoms of overactive bladder, improves patient reported quality of life, and is well tolerated: Results from a multicenter, phase III,

39

placebo controlled study. Society of Female Urology and Urodynamics, San Diego, CA, Feb 21 -24, 2007.

242. Dmochowski R, Parker R, Melkonian R. Effects of prior therapy on health related quality of lie following treatment with transdermal oxybutynin. Society of Female Urology and Urodynamics, San Diego, CA, Feb 21 -24, 2007.

243. Kaufman M, Harris C, Starkman J, Milam D, Scarpero H, Dmochowski R. Sacral neuromodulation for management of voiding dysfunction refractory to medical therapy following hysterectomy. Society of Female Urology and Urodynamics, San Diego, CA, Feb 21 -24, 2007.

244. Starkman J, Duffy John, Wolter Chris, Scarpero H, Dmochowski R. The effect of pubovaginal slings on mixed urinary incontinence. AUA annual meeting, Anaheim, CA, May 2007.

245. Starkman J, Duffy John, Wolter Chris, Scarpero H, Dmochowski R The Evolution of Obstruction-Induced Overactive Bladder Symptoms (OAB) Following Urethrolysis for Female Bladder Outlet Obstruction. AUA annual meeting, Anaheim, CA, May 2007.

246. Staskin D, Dmochowski R, Serels S, Andoh M, Hussain I. Report from a randomized, placebo controlled study showing significant improvement in urgency and patient reported outcomes in overactive bladder patients treated with solifenacin. International Urogynecologic Association meeting, Cancun, Mx. Sept, 2007.

247. Sand P, Staskin D, Zinner N, Dmochowski R. Once daily trospium chloride extended release is effective and well tolerated for the treatment of overactive bladder: Results from a multicenter phase III trial. ICS Annual Meeting, Rotterdam, NL, Aug, 2007.

248. Sand P, Dmochowski R, Zinner N, Staskin D. Trospium chloride extended release formulation provides effective relief for the symptoms of overactive bladder, imporves patient reported quality of life, and is well tolerated: Results from a multicenter, phase III, placebo controlled study. ICS Annual Meeting, Rotterdam, NL, Aug, 2007.

249. Khullar V, Rovner ES, Dmochowski R, Nitti V, Wang I, Guan E. Dose response relationship of fesoterodine 4 mg vs 8 mg and onset of action in subjects with overactive bladder: Results from a pooled analysis of 2 randomized trials. ICS Annual Meeting, Rotterdam, NL, Aug, 2007.

250. Dmochowski R, Staskin D, P Sand, Zinner N. Trospium chloride 60 mg once daily syndrome improves quality of life in subjects with overactive bladder. ICS Annual Meeting, Rotterdam, NL, Aug, 2007.

251. Starkman JS, Wolter Chistopher, Kaufman M, Dmochowski R, Scarpero H. Incontinence and pelvic reconstructive surgery: Practice patterns of southeastern section AUA urologists. Society of Female Urology and Urodynamics, Miami, FL, Feb 28 –Mar 2, 2008.

252. Dmochowski R, Dahl N. Effectiveness and safety of transdermal oxybutynin for overactive bladder in adults previously treated with orally administered oxybutynin. Society of Female Urology and Urodynamics, Miami, FL, Feb 28 –Mar 2, 2008.

253. Kaufman M, Wolter Chistopher, Lowrance W, Cole EE, Scarpero H, Dmochowski R, Cookson M, Smith. Voiding function in women with orthotopic neobladder diversion. Society of Female Urology and Urodynamics, Miami, FL, Feb 28 –Mar 2, 2008.

254. Wolter Chistopher, Kaufman M, Patel Sanjay, Scarpero H, Dmochowski R. Changes in voiding function after anterior compartment repair and pubovaginal sling. Society of Female Urology and Urodynamics, Miami, FL, Feb 28 –Mar 2, 2008.

255. Dmochowski R, Wein AJW. Antimuscarinic effect on severity of OAB. 4th International Consultation on Incontinence. Paris, France July 4 -8, 2008.

40

256. Rovner E, Dmochowski R, Watanabe J. ONCE DAILY TROSPIUM CHLORIDE 60 MG EXTENDED RELEASE IS SAFE AND EFFECTIVE IN PATIENTS WITH THE OVERACTIVE BLADDER SYNDROME WHO USE MULTIPLE CONCOMITANT MEDICATION. Society of Female Urology and Urodynamics, Las Vegas, NV, Feb 25 -28, 2009.

257. Kaufman, M.R., Wolter, C.E., Martinez-Ferrer, M., Bhowmick, N.A., Scarpero, H.S., and R.R. Dmochowski. Sildenafil reduces detrusor hypertrophy and fibrosis in a mouse model of bladder outlet obstruction. Fellow’s forum: SUFU, Las Vegas, NV, 25 Feb – 1 March, 2009

258. Kraus S, Dmochowski R, Roehrborn CJ , Kaminetsky KC, Xu L, Klise S Urodynamic effects of tadalafil 20 mg once daily versus placebo in men with signs and symptoms of benign prostatic hyperplasia. European Association of Urology, Stockholm Sweden, Mar, 17, 2009.

259. Dmochowski R, et al. Efficacy and Safety of Oxybutynin Chloride Topical Gel in Women With Overactive BladderA Randomized, Placebo-Controlled, Double-Blind Study. AUA Annual Meeting, Chicago, Ill. April, 2009.

260. Dmochowski R, Roehrborn C, Kraus S, Le X, Klise S. Changes in Bladder Outlet Obstruction Index in Men with Signs and Symptoms of Benign Prostatic Hyperplasia Treated with Tadalafil. AUA Annual Meeting, Chicago, Ill. April, 2009.

261. Dmochowski R, Chapple C, Nitti V, Chancellor M, Everaert K, Thompson C, Daniell G, Zhou J, Haag-Molkenteller C. Botulinum Toxin Type A (BOTOX®) Demonstrates Dose-Dependent Efficacy and Safety in Idiopathic Overactive Bladder: A Double-Blind, Placebo-Controlled, Randomized Trial. AUA Annual Meeting, Chicago, Ill. April, 2009.

262. Dmochowski R, Grier D, Franco N, et al .One Year Results from a World-Wide Registry of TVT-SECUR™ in Women with Stress Urinary Incontinence. AUA Annual Meeting, Chicago, Ill. April, 2009.

263. Manack A, Mostko S, Jones J, Ravelo A, Haag-Molkenteller C, Dmochowski R. EPIDEMIOLOGY OF NEUROGENIC BLADDER PATIENTS IN A US CLAIMS DATABASE. AUA Annual Meeting, Chicago, Ill. April, 2009.

264. Gries K, Campbell J, Watanabe J, Dmochowski R, Sullivan S. Characterization of Treatment Success for Overactive Bladder with Urinary Urge Incontinence Refractory to Oral Antimuscarinics. AUA Annual Meeting, Chicago, Ill. April, 2009.

265. Roehrborn C, Lei X, DmochowskiR, Krause S, Klise S. Reproducibility of Repeat Urodynamic Assessments from a Multicenter Trial in Men with Signs and Symptoms of Benign Prostatic Hyperplasia Following 12 Weeks of Placebo Treatment. AUA Annual Meeting, Chicago, Ill. April, 2009.

266. Stimson CJ, Cornett MB, Dmochowski R, Pichert J, Entman S, Hickson GB. Medical Malpractice Litigation Risk in Urology: An Ex Ante Empirical Analysis. AUA Annual Meeting, Chicago, Ill. April, 2009.

267. Kaufman, M.R., Wolter, C.E., Lowrance, W.T., Cole, E.E., Scarpero, H.M., Dmochowski, R.R., Cookson, M.S., and J.A. Smith, Jr. Voiding function in women with orthotopic neobladder diversion. Poster presentation: AUA Chicago, IL April 24 – 30, 2009.

268. Kaufman, M.R., Lewis, A., Wolter, C.E., Phillips, S.E., Maggi, D., Condry, L., Smith, J.A., Scarpero, H., and R.R. Dmochowski. Vesicovaginal fistula experience in Sierra Leone: Review of 505 cases. Moderated poster: AUA, Chicago, IL, 25 April – 30 April, 2009.

269. Dmochowski R. Darifenacin effectively relieves overactive bladder (OAB) symptoms

41

irrespective of baseline severity. International Urogynecologic Association. Como Italy, June 20, 2009.

COMMITTEE APPOINTMENTS: Local 1989 - 1993 Laser Committee, Naval Hospital, Portsmouth 1989 - 1993 Clinical Investigation Committee (Institutional Review Board) Naval Hospital, Portsmouth 1989 - 1993 Departmental Research Center Urology Department, Naval Hospital, Portsmouth 1991 - 1993 Facilitator, Total Quality Leadership, Directorate of Surgical Services Naval Hospital, Portsmouth 1993 Institutional Research Council, Naval Hospital, Portsmouth 1994 – 1997 Progress and Promotion Committee, UT Memphis (Basic Science) 1994 – 1998 Operating Room Committee (UT Bowld Hospital) 1995 – 1997 Medical Staff Advisory Committee, UT Bowld Hospital 1995 – 1998 Faculty Mentor Program, UT Medical School 1995 – 1998 Institutional Review Board, University of Tennessee 1995 – 1998 Faculty Senate 1996 – 1998 Quality Council, UT Bowld Hospital 1996 – 1998 Executive Committee, UT Bowld Hospital 1996 – 1998 Tissue Committee (chairman), U.T. Bowld Hospital 1997 – 1998 Strategic Planning Committee, U.T. Bowld Hospital 1997 – 1998 Basic Science Core Curriculum Committee (chair) University of Tennessee 2004 -Present Admissions Committee, Vanderbilt University School of Medicine 2006 -Present Chair, Section of Surgery Patient Safety Committee 2006 –Present Member, Institutional Review Board, Vanderbilt University School of Medicine 2008 –Present Chair, Catheter related urinary tract infection task force, Vanderbilt U Hospital 2009 –Present Member, Peri-operative Care Committee, Vanderbilt U Hospital National

42

1993 – 1997 Facilitator, American Urologic Association (AUA) Incontinence Guidelines Committee 1994 – 1998 Professional Advisory Board Member, Mid-South Chapter, National Multiple Sclerosis Society 1996 Clinical Evaluative Services Council, University Hospital Consortium 1996 AUA Representative, National Ostomy Guidelines Panel 1996 American College of Surgeons, Committee on Trauma (Tennessee Chapter) 1996 Member, Ostomy Guidelines Panel, National Ostomy Society 1997- 2003 Facilitator Coordinator American Urologic Association, Guidelines Initiative

Program 2000-2001 Member at large, Society for Female Urology and Urodynamics 2001- 2003 Secretary / Treasurer, Society for Female Urology and Urodynamics 2003 – 2005 Vice-Chair, AUA Coding and Reimbursement Committee (Terminology) 2000- 2006 Member, Erectile Dysfunction Guideline Panel, American Urologic Association 2001- 2005 Bladder Health Council, American Urologic Association 2001- 2006 Executive committee, National Association for Continence 2002- 2005 Executive committee, Genitourinary Reconstructive Surgery Society 2003- 2006 Vice-Chair, AUA Practice Parameters and Guidelines Committee 2003 – Present Member, AUA Coding and Reimbursement Committee (Terminology) 2003 – 2006 Member, Prostate Cancer Guideline Panel, American Urologic Association 2003 – 2006 Government Relations Committee, American Urogynecologic Society 2003 – 2007 International Continence Society Scientific Committee 2003 – 2008 International Continence Society Education Committee 2003 – Present Safety Committee, American Urologic Association 2003 – 2006 Vice President, Society for Female Urology and Urodynamics

43

2004 – 2006 American Urologic Association Blue Ribbon Committee on Outcomes for Prostate Cancer Treatment

2004 - Present Member ABOG / ABU Female Pelvic Medicine Fellowship Oversite Committee 2005 – 2008 Chair, AUA Practice Parameters and Guidelines Committee 2005 – 2008 Member, AUA Public Relations Committee 2006 - Present Member, AUA Pay for Performance Task Force 2006 - Present Vice chair, Stress Urinary Incontinence Guideline Panel, American Urologic

Association 2006 - 2008 President, Society for Female Urology and Urodynamics 2007 - 2008 AUA Core Curriculum Committee 2007 - 2008 Co-Chair, Committee on surgical management of incontinence, International

Consultation on Incontinence 2007 - Present Member, Medicare Evidence Development and Coverage Committee 2008 - Present Board Examiner, American Board of Urology 2008 - Present Member, Interstitial Cystitis Guideline Panel, American Urologic Association 2009 - Present Panel Member, FDA Gastroenterology and Renal Device Advisory Panel VISITING PROFESSORSHIPS: 1. University of Texas Southwestern Medical School, December 24, 1994. 2. Naval Medical Center, Portsmouth, Virginia, March 15, 1995. 3. Eastern Virginia Medical School, Norfolk, Virginia, January 19, 1996 4. Madigan Army Hospital, Seattle, Washington, February 1, 1996. 5. Eisenhower Army Hospital, Columbus, Georgia, December 10, 1996. 6. University of Alabama, Birmingham, Alabama, January 14, 1998. 7. Wilford Hall Medical Center, San Antonio, Texas, November 10, 1998. 8. LSU Medical Center, Shreveport, La., July 22, 1999. 9. Case Western Reserve, Cleveland, Oh., October 20, 1999. 10. Trippler Army Medical Center, Honolulu, Hi, July 17 –20, 2000. 11. University of Toronto, Toronto, Ca., April 27, 2001. 12. Long Island Jewish Hospital, New York, NY, Dec5-6, 2002. 13. University of New Mexico, Albuquerque, NM, Mar 7-8, 2003. 14. University of Florida, Gainesville, Fl, June 20, 2003. 15. Walter Reed Army Medical Center, July 9, 2004.

44

16. Tulane University Medical Center, October 13 -15, 2004. 17. University of Kansas Medical Center, April 30. 2005. 18. University of Chicago, April 6, 2006. 19. Geisinger Clinic, June 16, 2006. 20. Medical University of South Carolina, June 23, 2006 21. Wayne State Medical School, October 25, 2006 22. University of Pennsylvania, June 15, 2007 23. LSU / Oschner, Jan 17 -19, 2008 24. William Beaumont Hospital, Royal Oak, Michigan, June 21, 2008 25. Duke University Medical Center, Durham, NC, July 15, 2008 26 State University of New York, Buffalo, August 15 -16, 2008 27 Carolinas Medical Center, Charlotte, NC. June 5, 2009. INVITED LECTURES: 1. Dmochowski, R.: Update on Urologic Malignancy, American College of Surgeons Cancer

Management Course, Virginia Beach, Virginia. March 1993. 2. Dmochowski, R.: Evaluation and Surgical Therapy for Bladder Prolapse. Grand Rounds.

Baylor College of Medicine, Houston, Texas. October 1993 3. Dmochowski, R., Leach, G.E.: Vaginal Anatomy and Testing. Office Urology Course. AUA

Annual Meeting, San Francisco, California. May 1994. 4. Dmochowski, R.: Evaluation of Urinary Incontinence. Postgraduate Review Course. AUA

Annual Meeting, San Francisco, California. May 1994. 5. Dmochowski, R.: Evaluation of Adult Urinary Tract Infection. Family Practice Review

Seminar, Memphis, Tennessee. March, 1995. 6. Dmochowski, R.: Evaluation of Urinary Incontinence and Pelvic Prolapse in the Female.

Postgraduate Review Course, American Urological Association, Las Vegas, Nevada. April 1995.

7. Dmochowski, R.: Evaluation of Female Stress Urinary Incontinence. Grand rounds.

University of Chicago. October 1995.

45

8. Dmochowski, R.: New Frontiers in Urinary Incontinence. Hawaii Urologic Society. December 1995.

9. Dmochowski, R.: Trends in the Management of Stress Incontinence. Puget Sound Urologic

Society. January 1996. 10. Dmochowski, R.: The Evaluation and Surgical Management of Stress Urinary Incontinence.

Penninsula Urologic Society, Bremerton, Washington. February 1996. 11. Dmochowski, R.: Acute Urologic Emergencies. Emergency Medicine Update, Hot Springs,

Arkansas. March 1996. 12. Dmochowski, R.: New Surgical Therapies for Female Stress Urinary Incontinence. AORN

National Convention, Dallas, Texas. March 1996. 13. Dmochowski, R.: New Surgical Therapies for Female Stress Urinary Incontinence. Grand

Rounds, University of Kentucky, Lexington, Kentucky. April 1996. 14. Dmochowski, R.: 1. Injectable Agents for Stress Urinary Incontinence. 2. The Effect of Detrusor Instability and Urgency on Surgical Outcomes for Stress Urinary

Incontinence. 3. Retropubic Suspensions for Stress Urinary Incontinence.

Postgraduates Course, American Urologic Association Annual Meeting, Orlando, Florida. May 1996

15. Dmochowski, R.: New Techniques in the Surgical Management of Stress Urinary Incontinence.

Mississippi/Alabama Urologic Society, Gulfpoint, Mississippi. August 1996. 16. Dmochowski, R.: New Developments in Diagnosis and Management of Stress Incontinence,

Tri-Cities Urologic Society, Johnson City, Tennessee. September 1996. 17. Dmochowski, R.: Overview of Current Management of Female Stress Urinary Incontinence,

Orlando Urologic Society, Orlando, Florida. November 1996. 18. Dmochowski, R.: Controversies in the Diagnosis and management of Stress Urinary

Incontinence in Women, Columbus, Georgia. December 1996. 19. Dmochowski, R.: Guidelines and the Future for Urology and Surgical Management of Stress

Incontinence, Little Rock Urologic Society, Little Rock, Arkansas. January 1997. 20. Dmochowski, R.: 1. Diagnosis and Management of Female Stress Urinary Incontinence. 2. Benign Prostatic Hyperplasia: State of the Art. 3. Urinary Tract Infections: Pitfalls and Solutions. Tenth Annual Symposium on Clinical Medicine, Kauai, Hawaii. February 1997. 21. Dmochowski, R.: BPH: Current State of the Art. Twentieth Annual Family Practice Review

Course, Memphis, Tennessee. March 1997.

46

22. Dmochowski, R.: 1. Bulking Agents for Female Stress Urinary Incontinence. 2. Overview of Guidelines for Surgical Therapy for SUI.

Postgraduate Course, American Urologic Association, New Orleans, Louisiana . April 1997. 23. Dmochowski, R.: Incontinence in the Adult Female Myelodysplastic. Genitourinary

Reconstructive Surgery Society, New Orleans, Louisiana. April 1997. 24. Dmochowski, R.: The American Urologic Association Guidelines for the Surgical Management

of Female Stress Urinary Incontinence. Urodynamics Society, New Orleans, Louisiana. April 1997.

25. Dmochowski, R.: New Technologies for Treating Stress Urinary Incontinence. SUNA Annual

Meeting, New Orleans, Louisiana. April 1997. 26. Dmochowski, R.: Issues in Incontinence. Male and Female. Family Practice Update, 1997.

Memphis Tennessee. May 1997. 27. Dmochowski, R.: 1. Erectile Dysfunction . 2. Prostate Cancer.

University of Tennessee Family Practice Annual Review Course, Chattanooga, Tennessee. June 1997.

28. Dmochowski, R.: Panel Discussion - Stress Urinary Incontinence, Mid-Atlantic Section, AUA,

Homestead, W. Va. September 1997. 29. Dmochowski, R.: 1. Voiding Dysfunction in Children. 2. BPH and Lower Urinary Tract SYMPTOMS: Using Urodynamics to Sort Things Out. 3. Practical Urodynamics. 4. Female Urinary Incontinence: Evaluation and Management. 5. Pediatric Neurogenic Voiding Dysfunction: Medical Therapy.

Fourth Annual Asian Urology Association Meeting, Chiang Mai, Thailand. Dec. 1997. 30. Dmochowski, R.: The AUA Guidelines for Stress Urinary Incontinence and the Future of

Surgery for Stress Incontinence. Birmingham Urologic Society, Birmingham, Alabama. January 1998.

31. Dmochowski RR: 1.Neurophysiology of Voiding 2.Transvaginal Suspensions 3.Fascial Slings: Types and Results Experience 4.Intractable Detrusor Instability 5.Urethral Diverticula: Overview

Update in Urology and Urogynecology (Cleveland Clinic and Northwestern University). St. Thomas, V.I., Feb., 1998.

47

32. Dmochowski RR: Pelvic Reconstruction: State of The Art. Fourth Uniformed Services Urology Research Group. Denver, Co., Mar., 1998.

33. Dmochowski RR: Stress Incontinence: Diagnosis and Management. Thirty First Annual

Review Course for the Family Practitioner. Memphis, Tn. Mar., 1998. 34. Dmochowski RR: Occlusive and Supportive Devices in the Non-surgical Management of

Female Stress Urinary Incontinence. Plenary Session Presentation, A.U.A. Annual Meeting, San Diego, Ca. May, 1988.

35 Dmochowski RR: 1. Evaluation and diagnosis of stress urinary incontinence and vaginal prolapse. 2. Establishing and marketing a continence center. Postgraduate Course, A.U.A. Annual Meeting, San Diego, Ca. May, 1998. 36. Dmochowski RR: Overactive Bladder: Medical and Surgical Options. Tennessee Urologic Society. Chattanooga, Tn., Jul., 1998. 37. Dmochowski RR: 1.Establishing a Continence Center 2.New Strategies in Incontinence Management. Danville Uologic Society. Danville, Va., July, 1998. 38. Dmochowski RR: Understanding detrusor overactivity. North Florida Hospital. Orlando,

Fl. Oct., 1998. 39. Dmochowski RR: Improving outcomes measures for evaluation of stress urinary

incontinence interventions. Fourth Int. Outcomes Symposium. Houston, Tx., Oct. 1998 40. Dmochowski RR: Developments in the surgical management of stress urinary incontinence.

San Antonio Urologic Society, Nov. 1998. 41. Dmochowski RR: 1. The A.U.A. Guidelines 2. Synthetics and Anchors in incontinence surgery N.Y.U. Postgraduate Course, New York, N.Y., Dec., 1998. 42. Dmochowski RR: 1. Electrical Stimulation for Male Incontinence 2. Supportive Devices for Stress Incontinence 3. A.U.A. Guidelines 4. Algorithm for Incontinence Management A.U.A. Female Urology/ Incontinence Review Course, Washington, D.C., Dec, 1998. 43. Dmochowski RR: Intervention for the overactive bladder. Tampa Bay Urologic Society.

Jan., 1999. 44. Dmochowski RR: Surgical advances in incontinence. Austin Urologic Society. Feb., 1999. 45. Dmochowski RR: 1. Electrical stimulation in the management of urinary incontinence 2. Understanding voiding function and dysfunction 3. Coding and reimbursement for incontinence

48

Update in Urogynecology and Pelvic Reconstruction. Northwestern University, Chicago, Ill. Apr, 1999.

46 Dmochowski RR: Vaginal Devices. Urodynamic Society, Dallas, Texas. May, 1999. 47. Dmochowski RR: 1. The evaluation of urinary incontinence. 2. The essentials for establishing an incontinence center. Postgraduate Course, A.U.A. Annual Meeting, Dallas, Texas. May, 1999. 48 Dmochowski RR: Advances in incontinence. Texas Urological Society, Puerto Vallarta, Mex. May, 1999. 49. Dmochowski RR: Management of Overactive Bladder. Practice Update for the Primary Care Physicians, Hershey, Penn, July, 1999. 50. Dmochowski RR: Summary of Clinical Studies of Neuromodulation (U.S. data) International Continence Society, Denver, Co., Aug., 1999. 51. Dmochowski RR: 1. Electrical stimulation and electrical modulation 2. Vaginal supportive devices 3. AUA guidelines and the future 4. Incontinence therapy algorithm 5. The essentials of an incontinence center A.U.A. update on female urology and incontinence. Ft. Lauderdale, Fla. Sept., 1999. 52. Dmochowski RR: Advances in the therapy of bladder overactivity. Cleveland Urologic

Society, Cleveland, Oh., Oct., 1999. 53. Dmochowski RR: 1. Current anatomical concepts for stress urinary incontinence. 2. In-situ vaginal wall slings. 3. Cadaveric/ Synthetic slings. Sling-a -thon, Dallas, Texas, Oct., 1999. 54. Dmochowski RR: Advances in the therapy of detrusor instability. Georgetown University

Medical Center. Washington D.C., Oct., 1999. 55. Dmochowski RR: Understanding the demographics of Urinary Incontinence. American Public Health Association. Chicago, Ill., Nov, 1999. 56. Dmochowski RR: New trends in incontinence. Grand Rounds, Henry Ford Hospital, April,

2000. 57. Dmochowski RR: Advances in drug delivery for treatment of urinary incontinence. SUNA

Annual meeting, Atlanta, GA., May 2000. 58. Dmochowski RR: 1. Clinical research perspectives for continence centers. 2. The fundamentals for diagnosing urinary incontinence. Postgraduate course, A.U.A. Annual meeting, Atlanta, GA., May 2000.

49

59. Dmochowski RR: New advancements in the management of the urgency/frequency, urge

incontinence syndrome. Hawaii Urologic Society, Honolulu, HI, July, 2000. 60. Dmochowski RR: Evolution is surgical therapy for stress urinary incontinence. Grand

Rounds, Wilford Hall Medical Cneter, San Antonio, Tx, Sept., 2000. 61. Dmochowski RR: Pelvic pain, urgency and frequency. What is interstitial cystitis and what

is not. San Antonio Urologic Society, Sept., 2000. 62. Dmochowski RR: Supportive and occlusive vaginal devices, and peripheral electrical

stimulation. American College of Surgeons.Chicago, Il., Oct. 2000. 63. Dmochowski RR: Advances in the surgical management of incontinence. Grand Rounds,

Hospital of the Carolinas. Charlotte, N.C., Nov. 2000. 64. Dmochowski RR: Appropriate choices in sling materials. Grand Rounds,University of

Illinois, Chicago, Ill., Jan 2001 65. Dmochowski RR: 1.Clinical Evaluation of Voiding Dysfunction and Prolapse 2.Vesicovaginal Fistulas 3.Fascial Slings: What I do and Why 4.Urinary Retention and Other Complications of Incontinence Surgery 5.Medical Therapy for the Overactive Bladder

Update in Urology and Urogynecology (Baylor Medical School and Northwestern University). St. Thomas, V.I., Feb., 2001.

66. Dmochowski RR: Evolving technologies and injectable agents for stress urinary incontinence. American Lithotripsy Society, Charleston, SC, Mar 2001.

66. Dmochowski RR: 1.Advances in non-surgical management of incontience. 2.The essentials of an incontinent center. Louisiana Urologic Society. March, 2001. 67. Dmochowski RR: Slings and Injectable agents in the management on female urinary

incontinence. Grand Rounds, Vanderbilt University Medical Center, April, 2000. 68. Dmochowski RR: Injectable materials and the treatment of SUI. SUNA annual meeting.

Anaheim, Ca, 2001. 69. Dmochowski RR: Advancements in non-surgical therapy for incontinence Slings: Lessons learned Research in incontinence centers

Postgraduate course. AUA annual meeting. Anaheim, Ca, 2001. 70. Dmochowski RR: Surgical outcomes for pelvic organ prolapse surgery

Urodynamics Society annual meeting. Anaheim, Ca, 2001.

50

71. Dmochowski RR: Selection and choice of appropriate injectable agents. Costa Rican Urologic Congress. Costa Rica, July 28, 2001.

72. Dmochowski RR: Phamacologic innovations in voiding dysfunction. Capitol Urologic

Society. Albany, NY, Nov, 2001. 73. Dmochowski RR: Controversies in surgical management of incontinence. Grand Rounds,

Albany Medical College. Albany, NY, Nov, 2001. 74. Dmochowski RR: Diagnostic evaluation of incontinence and pelvic prolapse AUA guidelines and outcomes measures Injectable therapy for stress incontinence Surgical therapy for urethro-vaginal fistulas Vaginal cystocele repair Etiology of overactive bladder AUA postgraduate course, Keystone, Co, Jan, 2002. 75. Dmochowski RR: Advancements in drug delivery, bioavailability, and drug effect. Fourth

International Pelvic Floor Dysfunction Conference, Taormina, Sicily. Mar, 2002. 76. Dmochowski RR: Outcomes and in-situ vaginal wall slings. Urodynamics Society annual

meeting, Orlando, Fla., May 2002. 77. Dmochowski RR: Sling materials: what type is best. Plenary Session, AUA annual

meeting, Orlando, Fla, May 2002. 78. Dmochowski RR: Anatomy and Pathophsiology of SUI Sling materials: biologics. Injectable agents. Biomaterials in pelvic reconstruction Postgraduate course, AUA annual meeting, Orlando, Fla, May 2002. 79. Dmochowski RR: The overactive bladder: What it is and What to do about it. 3rd World

Congress on Controversies in obstetrics, gynecology and infertility. Washington, D.C., June 2002

80. Dmochowski RR: Implications and Considerations for Advancements in Incontinence.

Maryland Urologic Society. Sept, 2002. 81. Dmochowski RR: Optimizing Surgical Care of Stress Urinary Incontinence: Evaluation,

Selection and Outcomes. Women’s Pelvic Floor Disorders 2002 Symposium. Costa Mesa, Ca Oct, 2002.

82. Dmochowski RR: The Evolving Landscape of Surgical Intervention for SUI. Grand

Rounds. Eastern Virginia Medical School. Norfolk, Va., Oct 2002. 83. Dmochowski RR: Surgical Approaches to Pelvic Organ Prolapse Advances in Female Urology

51

Technologic Advances in Urology. Thomas Jefferson Medical School, Philadelphia, PA, Nov 2002.

84. Advances in Technology in Pharmacology and Surgery. NYU School of Medicine, New York,

NY Dec 6-7, 2002. Technologic innovations for the management of SUI in women Advances in pharmacotherapy for neurogenic voiding dysfunction 85. 50 th Kimbrough Military Urology Symposium Washington DC, December 10, 2002.

Female overactive bladder management: State of the Art. 86. New York Academy of Medicine. New York, NY, Jan 22, 2003. Debate: Controversies in the

choice of sling materials. 87. 2nd International Symposium on Pelvic Floor Disorders, Breckenridge, CO., Feb 16 – 18, 2003. Outcomes of incontinence and prolapse surgery Complications of vaginal surgery Algorithms for incontinence surgery 88. University of Kentucky CME series, Feb 25, 2003.

Getting a grip on overactive bladder

89. Southeastern Section AUA, Savannah, GA, March 28, 2003. Postgraduate seminar, Update on Female Urology 90. Society of Female Urology and Urodynamics, Chicago, Ill, April 27, 2003 Why do I do Urodynamics? Trends in coding and reimbursement for incontinence 91. American Urological Association, Chicago, Ill, April 29, 2003 Postgraduate course Advances in Female Urology and Incontinence 92. Cornell New York Hospital grand rounds, NY, NY, May 21, 2003. 93. Second International Symposium on Urogynecology, Miami, Fl, June 27 – 29, 2003. Outcomes and Interventions for SUI and Prolapse Pharmacology for the Overactive Bladder: Reality Testing Biologic vs. Synthetic Slings Vault Suspension and Enterocele Repair Ureteral Injury 94. Karolinska Institute. Stockholm Sweden, August28, 2003 Bulking agents for Female Stress Urinary Incontinence 95. University of California, San Diego November 24, 2004 Pharmacologic management of the overactive bladder

52

96. American Urologic Association Female Urology Postgraduate Course, Atlanta, Ga, Dec 6 -7,2003.

Current status of outcomes in urology Biologic materials Periurethral bulking Vesicovaginal fistulae Anterior Compartment Prolapse Diagnosis and management of OAB Future of drug therapy for OAB 97. University of Texas, Houston, Feb 13, 2004 Advancements in Pharmacologic Therapy for Voiding Dysfunction 98. 3rd International Symposium on Pelvic Floor Disorders, Breckenridge, CO., Feb 16 – 18, 2004. Symptom Assessment for voiding dysfunction What’s new and hot in urinary incontinence – US perspectives Pharmacologic therapy for UI 99. 9th Annual Issues in Pelvic Surgery, Nashville, Tn, Feb 20, 2004 Update on Pharmacotherapy for Voiding Dysfunction 100. 14th Annual Challenging Cases in Urology, Miami Fl, Feb 21, 2004. 101. 4th Annual Female Pelvic Floor Disorders Conference: Cleveland Clinic Florida. Ft Lauderdale

FL, Mar 12- 14, 2004. Postoperative Pain Bulking Therapy Allograft Slings Current status of Pharmacologic therapy for voiding dysfunction 102. Pittsburg PA Urologic Society, Mar 15, 2004. Pharmacotherapy for lower urinary tract symptoms 103. Female Pelvic Medicine and Reconstructive Surgery, Half Moon Bay, CA, Mar 19, 2004 Role of urodynamics in evaluation of incontinence Postoperative voiding dysfunction Sacral neuromodulation Nocturia 104. Female Urology and Urogynecology, 3rd Annual Course, Las Vegas NV, April 1-2,2004 Pharmacologic therapy and Botox injection for OAB Rectocele Repair 105. American Urological Association, Chicago, Ill, April 29, 2003 Medical Therapy for Stress Urinary Incontinence Highlights: Female Urology and Incontinence Postgraduate Course: Advances in Female Urology and Incontinence 106. International Continence Society, Paris, France, August 28, 2004 Highlights of Conference 107. University of Rochester, Rochester NY, Sept 8, 2004 Overactive Bladder: Issues and Controversies 108. Orleans Parish Medical Society /Nu Sigma Nu –Tulane University Lecture, New Orleans, La, Oct 13, 2004 Surgery for SUI: Fact, Fiction, and Reality 109. Korean Continence Society, Seoul, South Korea, October 23- 24, 2004 Male Urinary Incontinence Overview of OAB – Present and Future 110. Urology Update 2004, University of Toronto, Toronto, CA, Oct 29, 2004

53

Emerging trends in pharmacologic treatment of OAB and SUI Update on Bulking Therapy for SUI 111. New Solutions for Old Problems, Cedars-Sinai Medical Center, Los Angeles, Ca, Nov 12, 2004 Minimally invasive treatment options for stress incontinence Treatment of Urge/mixed incontinence Repair of complicated incontinence problems 112. AUA Postgraduate Course, San Diego, CA, Dec -5, 2004 Pharmacologic therapy for SUI Bulking Agents Biologic Materials for lower urinary tract indications Urethral Diverticula 113. University of Texas Southwestern Medical Center, Dallas Texas, Paul Peters Annual

Symposium Jan 20, 2005 OAB: Here and Now and the Not too Distant Future 114. Johns Hopkins, Baltimore MD, Houston Everett Symposium, Feb 18, 2005 Radiofrequency Suspension: Viable Alternative for SUI Pharmacotherapy for SUI Drugs for OAB: Are They Realistic? 115. Society of Female Urology and Urodynamics. Orlando Fl, Feb 24-26, 2004. Outcomes for SUI 116. Female Urology and Urogynecology, 3rd Annual Course, Las Vegas NV, Mar 30 – Apr 1,2005 Interstitial cystitis and pelvic pain disorders Biologic materials for slings and incontinence surgery Pharmacologic intervention for OAB Outcomes for pharmacotherapy for SUI 117. Boston Urologic Society, Boston, MA. April 14, 2005 Surgery for incontinence and prolapse: a changing landscape 118. Kansas City Urologic Society, Kansas City, KA, April 29, 2005 Overactive Bladder Therapy: State of the Art 119. AUA Postgraduate Course, San Antonio, Tx, May 2005 Overactive Bladder: Advancements and Controversies 120. Society of Genitourinary Reconstructive Surgeons, San Antonio, Tx, May 2005 Vesicovaginal Fistulae: Evolution of Care 121. William Beaumont Hospital, Urology Grand Rounds, Royal Oak, MI, June 2005 Evolving Management of the Overactive Bladder 122. Wayne State Medical School, Urology Grand Rounds, Royal Oak, MI, June 2005 Evolving Management of the Overactive Bladder 123. International Continence Society. Montreal, Ca August, 2005. Outcomes of mid-urethral slings Anterior Compartment Repair Using Porcine Interposition Grafts Advances and controversies in treatment of genital prolapse Future of intravesical therapy for OAB 124. Cincinnati Urologic Society, Cincinnati,OH, October 17, 2005 Surgery for Incontinence: Now and the Future 125. Society of Urodynamics and Female Urology, Freeport, Bahamas, Feb 23 -25, 2006 Case discussion: Complicated Incontinence 126. Sixth Annual Female Pelvic Disorders Symposium. CCF, Ft Lauderdale, FL, March10-12, 2006 Cystocele Repairs Bulking Agents for SUI

54

Pharmacotherapy for lower urinary tract disorders 127. Mayo Clinic Urogynecology and Disorders of the Female Pelvic Floor, Scottsdale, AZ, March 24, 2006 Lower urinary tract pharmacologic agents Bulking agents for SUI Cystoscopy as Adjunct to Pelvic Reconstructive Surgery 128. Fifth Annual Female Urology and Urogynecology Review Course, Philadelphia, PA, April 10 – 12, 2006 Lower urinary tract physiology Primary therapy for overactive bladder Bladder and ureteral injuries 129. Thai Urologic Association, Cha Am, Thailand, May 10 -13, 2006 Post Prostatectomy Incontinence

Advance in Female Urinary Incontinence and Pelvic Organ Prolapse Surgery

130. AUA Postgraduate Course, San Diego, CA, Atlanta, Ga. May 21, 2006 Overactive Bladder: Advancements and Controversies 131. Grand rounds, Dept of Ob / Gyn, Temple University, Philadelphia, PA, June 21, 2006. Overactive Bladder: An evolving syndrome. 132. Post graduate course, 24thWorld Congress of Endourology, Cleveland, OH August 18,2006 Mid-urethral slings 133. International Urogynecologic Association, Athens, Greece, Sept 6, 2006 Botox: Patient Selection: Responders vs. Non – responders 134. Italian Urodynamic Society, Rome, Italy. Sept 29, 2006. Obstruction following incontinence surgery in women 135. Iowa Urologic Society, Iowa City, IA, Sept 29, 2006 Mid-urethral slings; an evolution Pharmacologic Intervention for the lower urinary tract 136. Pierce Memorial Lecture, Dearborn, MI October 25, 2006 Guidelines and the future of Urology 137. AUA Post graduate course in Female Urology, Philadelphia, PA, Oct 26, 2006 Outcomes for urologic interventions Urethral Diverticula Pelvic organ prolapse, what a Urologist should know Urethral bulking agents 138. AUA Post graduate course in Female Urology, Tucson, AZ. Jan 26 -30, 2007 Bladder physiology and pathophysiology Office management of incontinence and pelvic organ prolapse Managing complications of pelvic surgery Pelvic prolapse for the urologist Urethral reconstruction Neuromodulation for bladder overactivity and underactivity 139. McGill University, Urology and Urogynecology, Quebec, Canada. Feb 8 – 9, 2007 Complications of Mid-urethral Slings Management of Refractory OAB Surgery for Stress Urinary Incontinence Procedural Innovation: TVT-S 140. University of California, Los Angeles, State of the Art Conference, March 8 -9, 2007

55

What to do when a mid-urethral sling fails Urethral bulking agents: update Voiding dysfunction and Interstitial Cystitis 141. HMDP Visiting Lecturer, Singapore What to do with sling failures Pelvic Pain and interstitial cystitis Botulinum toxin for urinary disorders Outlet obstruction in women Refractory detrusor overactivity 142. Sixth Annual Female Urology and Urogynecology Review Course, Las Vegas, NV, April 25-28 2006 Interstitial Cystitis: What we think we know Urethral Obstruction Diagnosis and Management of Urethral Injury Vesicovaginal fistulas Neurogenic Bladder Sling composition does it make a difference 143. AUA Postgraduate Course, Los Angeles, CA, May 24, 2007 Overactive Bladder: Advancements and Controversies 144. Grand Rounds Medical College of Georgia, Augusta, Ga., June 28, 2007 The state of surgical reconstruction for incontinence and prolapse 145. American Urologic Association Summer Research Forum, Los Angeles, Ca, August 4, 2007 Practice Guidelines: Process and Status 146. Washington DC Urologic Society, October 23, 2007 Surgical management of urinary incontinence and pelvic organ prolapse: State of the art 147. Perspectives in Urology: Point Counterpoint, Scottsdale AZ. November 9, 2007 Technique for intradetrusor BOTOX injection An overview of female urology: State of the art Overactive bladder Next generation of the male sling 148. Urology Grand Rounds, University of Miami, Miami Fl, Nov 16, 2007 State of the Art in Overactive Bladder 149. Chicago Urologic Society, Chicago Ill, Dec 5, 2007 Trends in pelvic reconstruction and incontinence surgery 150. Edgar Burns Lectureship, LSU/ Oschner, New Orleans, La. Jab 17 -19, 2008 Complications of surgery for SUI Pelvic organ prolapsed surgery: What the urologist should know What the AUA Guidelines tell about SUI surgery 151. Kimbrough Urologic Symposium, San Diego Ca, Jan 23, 2008 Advances in female pelvic medicine 152. University of California San Francisco, Post Graduate, Course. San Francisco, CA, Feb 9, 2008 Surgical outcomes and evidence, what the AUA guidelines tell us Interstitial cystitis: What is the bottom line? What randomized trials tell us about OAB therapy Neuromodulation for refractory voiding dysfunction 153. 21st Annual Aspen Urological Conference, Aspen CO, Feb 11-15, 2008 Detrusor dysfunction – towards a comprehensive treatment strategy Male incontinence – What are the best options?

56

What are the real and meaningful outcomes for female stress incontinence surgery To mesh or not to mesh: do we really know what is best for prolapse repair

154. Evidence Based Medicine, Institute of Medicine, Washington, DC, Mar 31, 2008 The AUA Guidelines and evidence based medicine 155. ASEAN / Thai Urologic Association Combined meeting, Pattaya, Thailand, April 22-25,2008. Advances in post-prostatectomy incontinence therapy Bulking therapy for SUI in women Medical therapy for men with voiding dysfunction 156. Society of Urology Clinical Program Directors, Orlando, Fl, May 16, 2008 Core Surgical Cases for Female Urology 157. AUA Postgraduate Course, Orlando, Fl, May 18, 2008.

Complications of incontinence and prolapse surgery: Evaluation, Intervention and Resolution - A review from both specialties.

158. American Urologic Association, Orlando, Fl. May 18, 2008 AUA Guidelines; Progress,Process and the Future 159. Harry Lichtwardt Lectureship, William Beaumont Hospital, Royal Oak, Michigan, June 21, 2008-07-04 The future of urology in pelvic medicine. 160. Caremark National P/T Committee, Chicago, Il, Aug 5, 2008 The Syndrome of overactive bladder, epidemiology, diagnosis, therapy 161. Xth Paulista Conference, Sao Paolo, Brazil. Sept 4 -6, 2008 Urogenital fistula management Adjustable devices for post prostatectomy incontinence Geriatric incontinence Management of chronic pelvic pain 162. Fiftieth Anniversary University of Florida Dept of Urology, Oct 1, 2008-10-10 Female Urology and the future of urology 163. Female Urology and Voiding Dysfunction, New Orleans, La, Oct 17 -18,2008 Laparoscopy and robotics in female urology Neuromodulation for voiding dysfunction Complications of surgery for stress urinary incontinence Urethral bulking for stress incontinence Pelvic organ prolapse, what the urologist should know 164. Victoria Medical Society, Melbourne, Australia, Oct 23 -25, 2008 Trends in education for female urology and pelvic medicine What’s new in female urology and pelvic reconstruction

Measuring outcomes for interventions for pelvic prolapse and incontinence

165. San Diego Urologic Society, Sand Diego, CA Nov 6, 2008-11-07 The Future of urology as viewed from a sub-specialty 166. NIDDK Symposium: New Directions for Research in Urinary Incontinence , Bethesda,,MD. Jan 09, 2009

What are the Components Necessary to Develop Good Trials Design?:Urge incontinence

What would Ten years from now look like? 167. Society of Government Service Urologists, Washington, DC. January 14, 2009 The treatment of refractory overactive bladder; where are we now?

57

168. Rodney Appell Memorial Update In Gynecologic Urology. Aruba, February 5-7,2009. Managing SUI: where are now

How does Neurogenic Bladder influence the management of stress incontinence and prolapsed

Is completey dry for real? Overactive bladder: etiology and diagnosis Injectable agents for stress incontinence Overactive bladder; the bladder on drugs Vaginal vault prolapsed-vaginal repairs without mesh 169. Female Urology and Urogynecology, 8th Annual Course, Washington DC, March 27 -29,2008 Drugs for OAB Botox and neuromodulation Sling composition; does it make a difference? Vesicovaginal and ureterovaginal fistula Identification and management of ureteral and bladder injuries 170. Confederation of Latin American Urology, Chicago, Ill. April 25, 2008 Overactive bladder: State of the art 171. AUA Postgraduate Course, Chicago, Ill, April 26, 2009.

Complications of incontinence and prolapse surgery: Evaluation, Intervention and Resolution - A review from both specialties

172. International Urogynecologic Association. Como Italy, June 20, 2009. Regulatory review of urologic devices: The North American view 173. Canadian Urologic Association. Toronto, Canada, June 29, 2009-06-30

The Future of Female Urology: Does the Urologist have a role in the care of the female patient

Evaluation of post-prostatectomy incontinence RESEARCH 1. Duloxitene in Stress Urinary Incontinence. Eli Lilly Company (completed). 2. Autocath 100, Implantable Urethral Sphincter Mechanism. H/K Medical Technologies.

(completed). 3. Endolumenal Ultrasonography of the Lower Urinary Tract. Boston Scientific Corporation. 4. Implantable Urethral Stent for Urethral Stricture Disease. Boston Scientific Corporation

(completed). 5. Cadaveric Dissection Studies of Neural Anatomy of Male/Female Urethral Sphincteric

Mechanism.(completed) 6. Long-Term Urodynamic Investigation of Bladder function in Patients with Cyclophosphomide

Toxicity Related to Bladder Complications (cooperative study w2ith St. Jude’s Research Hospital). (completed)

58

7. Nitric Oxide Byproducts as Potential Carcinogens in Spinal Cord Injured Patients with Chronic Indwelling Catheters. (VAMC Memphis.)

8. Neurostimulation for Voiding Dysfunction. Medtronics. 9. Transdermal Oxybutynin in Patients with Urge Urinary Incontinence: A 12-Week

MultiCenter, Randomized, Double-Blind, Placebo-Controlled Study with a 12-Week Open-Label, Dose-Titration, Safety Extension. Watson Pharm

10. A Phase 1-2 Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of Intravesical

Oxybutynin solution in Patients with Urge Incontinence. Situs Corp 11. A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Fixed-Dose, Parallel

Group, 6-Month Comparison Study to Investigate the Efficacy and Safety of the Phosphodiesterase Type V Inhibitor BAY 38-9456 in Males with Erectile Dysfunction. Bayer Pharm

12 Abbreviated Protocol for the Clinical Investigation of the SURx Probe in the Treatment of

Female Stress Urinary Incontinence Using a Transvaginal Approach. Surx Corp 13. A Multicenter Randomized Controlled Study to Evaluate the Safety and Effectiveness of

URYX Urethral Bulking Agent in Patients with Urinary Incontinence. Genyx 13. A Randomixed Trial of Allogeneic Human Tissue Matrix Injection (Urologen) vs. ovine

Collagen Injection (Contigen) for the Treatment of Stress Urinary Incontinence. Collagenisis Corp

14. A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Safety

and Efficacy of XXXXX in the Treatment of Adult Patients with Overactive Bladder. Forest Pharm

15. A 12-Week Safety and Efficacy Study of Oral TAK-637 Versus Placebo in Subjects with

Overactive Bladder. TAP Pharm 16. A 52-Week Extension Study to Evaluate Long-Term Safety of Oral TAK-637 in Subjects

with Overactive Bladder. TAP Pharm 17. Comparison of the Efficacy and Tolerability of Ditropan XL and Detrol in the Treatment of

Overactive Bladder. Alza Pharm 18. A Phase III Study of the Efficacy and Safety of ABT-980 in Subjects with Symptomatic

Benign Prostatic Hyperplasia. Abbott Pharm 19. A Prospective Evaluation of the Urethral Drainage Stent (UDS) for Patients with Urinary

Retention Secondary to Prostate Obstruction. Boston Scientific Corp 20. Evaluation of the Urologix, Inc. Targis System Shortened Treatment Compared to a Standard

Treatment for Benign Prostatic Hyperplasia. Targis Corp

59

21. A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Study Comparing the

Safety, Tolerance and Efficacy of RTX (reiniferatoxin) Topical Solution in Patients with Detrusor Hyperreflexia. Afferon Corp

22. The Safety, Local Tolerability, Pharmacokinetics, and Risk/Benefit of

Oxybutynin Transvaginal Ring (TVR) in Women with a History of Overactive Bladder. Advnaced Biologics

23. An Open Evaluation of the Safety and Clinical Utility of E-Trans (fentanyl) For the Management of Post-Operative Pain in the Home Environment . Alza Pharm 24. Prospective, Randomized, Double-Blind, Multi-Center, Comparative Trial to Evaluate the

Efficacy and Safety of Ciprofloxacin Once-Daily (OD) Modified Release (CIPRO MR) Tablets 1000mg vs Conventional Ciprofloxacin 500mg Tablets BID in the 7-14 Day Treatment of Patients with Complicated Urinary Tract Infections (cUTI) or Acute, Uncomplicated Pyelonephritis. Bayer Pharm

25. A Prospective, Randomized, Comparative Parallel Group Study of CoapTite and Contigen for

Urethral Sphincter Augmentation in the Treatment of Stress Incontinence in a Female Population. Bioform Corp.

26. Urological Xenograft Sling Clinical Study Protocol. Advanced Biologics 27. A Two-Phase, Double-Blinded, Randomized, Parallel-Group Design, Multicenter Study of

FLOMAX Capsules, 0.4mg Versus Placebo in Male Patients with Acute Urinary Retention Related to Benign Prostatic Hyperplasia. Boehringer Ingelheim

28 An Eight Week, Double-Blind, Randomized, Parallel Group Design, Multicenter Study of

FLOMAX Capsules, 0.4mg Daily Versus Placebo, in Female Patients with Lower Urinary Tract Symptoms (LUTS) with a Significant Component of Voiding Symptoms. . Boehringer Ingelheim

29. Efficacy and Safety of Duloxetine Compared with Placebo in Subjects with Stress Urinary

Incontinence. Eli Lilly 30. Long-Term Monitoring of Safety in Subjects Treated with Duloxetine for Stress Urinary

Incontinence. Eli Lilly 31 A Patient Acceptability Study of a Once-Daily Formulation of Tolterodine. A Phase IIIB,

Open-Label, Single-Arm Trial in Adult Patients with Overactive Bladder and Symptoms of Urinary Frequency, Urgency, and/or Urge Incontinence. Pharmacia Upjohn

32. A Multicenter, Phase III, Double Blind, Placebo Controlled, Flexible Dose Study to Evaluate

the Efficacy and Safety of Viagra in Women who have Female Sexual Dysfunction Resulting from a Traumatic Spinal Cord Injury. Pfizer

33. The Study of Onset of Action of Alfuzosin 10mg Once Daily Formulation in Symptomatic

Subjects with Benign Prostatic Hyperplasia (Alpha Blocker Responders). Sanofi-Synthelabo

8/09 CURRICULUM VITAE · Urologic Clinics: Advances in Incontinence Surgery. ed R Dmochowski. WB...

Documents

Transcript of 8/09 CURRICULUM VITAE · Urologic Clinics: Advances in Incontinence Surgery. ed R Dmochowski. WB...